cached image

John C. Morris, MD - Publications

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
http://www.researchprofiles.collexis.com/jad/expertProfile.asp?n=&u_id=8
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/morris.htm

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Millar PR, Luckett PH, Gordon BA, Benzinger TL, Schindler SE, Fagan AM, Cruchaga C, Bateman RJ, Allegri R, Jucker M, Lee JH, Mori H, Salloway SP, Yakushev I, Morris JC, et al. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. Neuroimage. 119228. PMID 35452806 DOI: 10.1016/j.neuroimage.2022.119228  0.544
2022 Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, ... ... Morris JC, et al. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. PMID 35450967 DOI: 10.1212/WNL.0000000000200358  0.517
2022 Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, ... ... Morris JC, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661  0.566
2022 Strain JF, Barthelemy N, Horie K, Gordon BA, Kilgore C, Aschenbrenner A, Cruchaga C, Xiong C, Joseph-Mathurin N, Hassenstab J, Fagan AM, Li Y, Karch CM, Perrin RJ, Berman SB, ... ... Morris JC, et al. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. Neurobiology of Disease. 168: 105714. PMID 35358703 DOI: 10.1016/j.nbd.2022.105714  0.564
2022 Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, ... Morris JC, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. The Lancet. Neurology. 21: 329-341. PMID 35305339 DOI: 10.1016/S1474-4422(22)00027-8  0.605
2022 Wang Q, Chen G, Schindler SE, Christensen J, McKay NS, Liu J, Wang S, Sun Z, Hassenstab J, Su Y, Flores S, Hornbeck R, Cash L, Cruchaga C, Fagan AM, ... ... Morris JC, et al. Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35260470 DOI: 10.1212/NXI.0000000000001152  0.32
2022 McKay NS, Dincer A, Mehrotra V, Aschenbrenner AJ, Balota D, Hornbeck RC, Hassenstab J, Morris JC, Benzinger TLS, Gordon BA. Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults. Neurobiology of Aging. 112: 181-190. PMID 35227946 DOI: 10.1016/j.neurobiolaging.2021.12.012  0.544
2022 Meeker KL, Butt OH, Gordon BA, Fagan AM, Schindler SE, Morris JC, Benzinger TLS, Ances BM. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiology of Disease. 105662. PMID 35167933 DOI: 10.1016/j.nbd.2022.105662  0.53
2022 Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Morris JC, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6  0.579
2022 Wilks H, Aschenbrenner AJ, Gordon BA, Balota DA, Fagan AM, Musiek E, Balls-Berry J, Benzinger TLS, Cruchaga C, Morris JC, Hassenstab J. Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 35037593 DOI: 10.1080/13803395.2021.2009447  0.539
2021 Koenig LN, LaMontagne P, Glasser MF, Bateman R, Holtzman D, Yakushev I, Chhatwal J, Day GS, Jack C, Mummery C, Perrin RJ, Gordon BA, Morris JC, Shimony JS, Benzinger TLS, et al. Regional age-related atrophy after screening for preclinical alzheimer disease. Neurobiology of Aging. 109: 43-51. PMID 34655980 DOI: 10.1016/j.neurobiolaging.2021.09.010  0.501
2021 Hassenstab J, Nicosia J, LaRose M, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Xiong C, Morris JC. Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease. Alzheimer's Research & Therapy. 13: 153. PMID 34517889 DOI: 10.1186/s13195-021-00894-5  0.555
2021 Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9  0.571
2021 Schindler S, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, Coble D, Klunk WE, Fagan AM, Holtzman D, Bateman RJ, Morris JC, Xiong C. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET. Neurology. PMID 34504028 DOI: 10.1212/WNL.0000000000012775  0.573
2021 Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, ... ... Morris JC, et al. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica. PMID 34319442 DOI: 10.1007/s00401-021-02342-y  0.505
2021 Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197  0.559
2021 Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197  0.559
2021 Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, ... ... Morris JC, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8  0.549
2021 Harrington KD, Aschenbrenner AJ, Maruff P, Masters CL, Fagan AM, Benzinger TLS, Gordon BA, Cruchaga C, Morris JC, Hassenstab J. Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518. PMID 34043464 DOI: 10.1177/0956797620985518  0.514
2021 Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929  0.315
2021 Boerwinkle AH, Wisch JK, Chen CD, Gordon BA, Butt OH, Schindler SE, Sutphen C, Flores S, Dincer A, Benzinger TLS, Fagan AM, Morris JC, Ances BM. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease. Neurology. PMID 33931538 DOI: 10.1212/WNL.0000000000012123  0.59
2021 Butt OH, Long JM, Henson RL, Herries E, Sutphen CL, Fagan AM, Cruchaga C, Ladenson JH, Holtzman DM, Morris JC, Ances BM, Schindler SE. Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25. Neurobiology of Aging. 102: 64-72. PMID 33765432 DOI: 10.1016/j.neurobiolaging.2021.02.008  0.307
2021 Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112  0.555
2021 Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, ... ... Morris JC, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542  0.521
2021 Luckett PH, McCullough A, Gordon BA, Strain J, Flores S, Dincer A, McCarthy J, Kuffner T, Stern A, Meeker KL, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, ... ... Morris JC, et al. Modeling autosomal dominant Alzheimer's disease with machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480178 DOI: 10.1002/alz.12259  0.49
2021 Smith R, Strain J, Tanenbaum A, Fagan A, Hassenstab J, Mcdade E, Schindler S, Gordon B, Xiong C, Chhatwal J, Jack CR, Karch C, Berman S, Brosch J, Lah J, ... ... Morris J, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. PMID 33430685 DOI: 10.1089/brain.2020.0808  0.521
2020 Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, ... ... Morris JC, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage. Clinical. 28: 102491. PMID 33395982 DOI: 10.1016/j.nicl.2020.102491  0.512
2020 Babulal GM, Johnson A, Fagan AM, Morris JC, Roe CM. Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept. Journal of Alzheimer's Disease : Jad. PMID 33361605 DOI: 10.3233/JAD-201294  0.341
2020 Mozersky J, Hartz S, Linnenbringer E, Levin L, Streitz M, Stock K, Moulder K, Morris JC. Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results. Journal of Alzheimer's Disease : Jad. PMID 33337371 DOI: 10.3233/JAD-200993  0.328
2020 Meeker KL, Ances BM, Gordon BA, Rudolph CW, Luckett P, Balota DA, Morris JC, Fagan AM, Benzinger TL, Waring JD. Cerebrospinal fluid Aβ42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability. Neurobiology of Aging. 98: 116-123. PMID 33264709 DOI: 10.1016/j.neurobiolaging.2020.10.027  0.527
2020 Chen CD, Holden TR, Gordon BA, Franklin EE, Li Y, Coble DW, Luo H, Bateman RJ, Ances BM, Perrin RJ, Benzinger TLS, Cairns NJ, Morris JC. Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease. Annals of Clinical and Translational Neurology. PMID 33150749 DOI: 10.1002/acn3.51237  0.568
2020 Millar PR, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating Cognitive Relationships with Resting-State and Task-driven Blood Oxygen Level-Dependent Variability. Journal of Cognitive Neuroscience. 1-24. PMID 33135966 DOI: 10.1162/jocn_a_01645  0.426
2020 Meeker KL, Wisch JK, Hudson D, Coble D, Xiong C, Babulal GM, Gordon BA, Schindler SE, Cruchaga C, Flores S, Dincer A, Benzinger TL, Morris JC, Ances BM. Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework. Annals of Neurology. PMID 33111990 DOI: 10.1002/ana.25948  0.533
2020 Millar PR, Ances BM, Gordon BA, Benzinger TLS, Fagan AM, Morris JC, Balota DA. Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease. Neurobiology of Aging. 96: 233-245. PMID 33039901 DOI: 10.1016/J.Neurobiolaging.2020.08.007  0.578
2020 Denny A, Streitz M, Stock K, Balls-Berry JE, Barnes LL, Byrd GS, Croff R, Gao S, Glover CM, Hendrie HC, Hu WT, Manly JJ, Moulder KL, Stark S, Thomas SB, ... ... Morris JC, et al. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33034414 DOI: 10.1002/Alz.12160  0.365
2020 Goyal MS, Gordon BA, Couture LE, Flores S, Xiong C, Morris JC, Raichle ME, L-S Benzinger T, Vlassenko AG. Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain. Neurobiology of Aging. 96: 165-175. PMID 33011615 DOI: 10.1016/J.Neurobiolaging.2020.08.019  0.565
2020 Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, ... ... Morris JC, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102  0.517
2020 Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Morris JC, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178  0.406
2020 Sheline YI, Snider BJ, Beer JC, Seok D, Fagan AM, Suckow RF, Lee JM, Waligorska T, Korecka M, Aselcioglu I, Morris JC, Shaw LM, Cirrito JR. Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial. Neurology. PMID 32913021 DOI: 10.1212/Wnl.0000000000010725  0.33
2020 Olive C, Ibanez L, Farias FHG, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U, Del-Aguila J, Bergmann K, Bradley J, Benitez BA, Harari O, et al. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. Journal of Alzheimer's Disease : Jad. PMID 32894242 DOI: 10.3233/Jad-200019  0.317
2020 Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747  0.437
2020 Li H, Knight WC, Yang P, Guo Y, Perlmutter JS, Morris JC, Bateman RJ, Benzinger TLS, Xu J. Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype. International Journal of Molecular Sciences. 21. PMID 32842621 DOI: 10.3390/Ijms21176047  0.404
2020 Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. Association of education with Aβ burden in preclinicial familial and sporadic Alzheimer disease. Neurology. PMID 32759192 DOI: 10.1212/Wnl.0000000000010314  0.428
2020 Keleman A, Wisch JK, Bollinger RM, Grant EA, Benzinger TL, Morris JC, Ances BM, Stark SL. Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32741815 DOI: 10.3233/Jad-200192  0.466
2020 Aschenbrenner AJ, Petros J, McDade E, Wang G, Balota DA, Benzinger TL, Cruchaga C, Goate A, Xiong C, Perrin R, Fagan AM, Graff-Radford N, Ghetti B, Levin J, Weidinger E, ... ... Morris JC, et al. Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12038. PMID 32587883 DOI: 10.1002/Dad2.12038  0.454
2020 Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, ... ... Morris JC, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960. PMID 32522711 DOI: 10.1016/J.Nbd.2020.104960  0.533
2020 Stojanovic M, Jin Y, Fagan AM, Benzinger TL, Hassenstab J, Cruchaga C, Morris JC, Head D. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer Disease and Associated Disorders. PMID 32520736 DOI: 10.1097/Wad.0000000000000385  0.375
2020 Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, Benzinger TL, Morris JC, Ances BM. Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT). Alzheimer Disease and Associated Disorders. PMID 32520734 DOI: 10.1097/Wad.0000000000000393  0.558
2020 Millar PR, Petersen SE, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating the Sensitivity of Resting-State BOLD Variability to Age and Cognition after Controlling for Motion and Cardiovascular Influences: A Network-Based Approach. Cerebral Cortex (New York, N.Y. : 1991). PMID 32515824 DOI: 10.1093/Cercor/Bhaa138  0.503
2020 Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, ... ... Morris JC, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 581: 71-76. PMID 32376954 DOI: 10.1038/S41586-020-2247-3  0.448
2020 Koenig LN, Day GS, Salter A, Keefe S, Marple LM, Long J, LaMontagne P, Massoumazada P, Snider BJ, Kanthamneni M, Raji CA, Ghoshal N, Gordon BA, Miller-Thomas M, Morris JC, et al. Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia. Neuroimage. Clinical. 26: 102248. PMID 32334404 DOI: 10.1016/j.nicl.2020.102248  0.563
2020 Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biological Psychiatry. PMID 32228870 DOI: 10.1016/J.Biopsych.2020.01.023  0.418
2020 Day GS, Rappai T, Sathyan S, Morris JC. Deciphering the factors that influence participation in studies requiring serial lumbar punctures. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12003. PMID 32211499 DOI: 10.1002/Dad2.12003  0.324
2020 Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z  0.601
2020 Aschenbrenner AJ, Gordon BA, Fagan AM, Schindler SE, Balota DA, Morris JC, Hassenstab JJ. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144992 DOI: 10.3233/Jad-200018  0.588
2020 Babulal GM, Roe CM, Stout SH, Rajasekar G, Wisch JK, Benzinger TLS, Morris JC, Ances BM. Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults. Journal of Alzheimer's Disease : Jad. PMID 32144985 DOI: 10.3233/Jad-191078  0.379
2020 Wisch JK, Roe CM, Babulal GM, Schindler SE, Fagan AM, Benzinger TL, Morris JC, Ances BM. Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144983 DOI: 10.3233/Jad-191039  0.41
2020 Xiong C, Luo J, Coble D, Agboola F, Kukull W, Morris JC. Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32067357 DOI: 10.1002/Alz.12060  0.447
2020 Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, ... ... Morris JC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032  0.603
2020 Levine TF, Allison SL, Stojanovic M, Fagan AM, Morris JC, Head D. Spatial navigation ability predicts progression of dementia symptomatology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043719 DOI: 10.1002/Alz.12031  0.366
2020 Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, ... ... Morris JC, et al. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathologica Communications. 8: 5. PMID 31996268 DOI: 10.1186/S40478-020-0879-Z  0.405
2020 Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, Fagan AM, McCue L, Xiong C, Morris JC, Benzinger TLS, Holtzman DM. Erratum: Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease (Science Translational Medicine DOI: 10.1126/scitranslmed.aau6550) Science Translational Medicine. 12. PMID 31915302 DOI: 10.1126/Scitranslmed.Aba5187  0.323
2020 Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Morris JC, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010  0.344
2019 Contreras JA, Aslanyan V, Sweeney MD, Sanders LMJ, Sagare AP, Zlokovic BV, Toga AW, Han SD, Morris JC, Fagan A, Massoumzadeh P, Benzinger TL, Pa J. Functional connectivity among brain regions affected in Alzheimer's disease is associated with CSF TNF-α in APOE4 carriers. Neurobiology of Aging. PMID 31870643 DOI: 10.1016/J.Neurobiolaging.2019.10.013  0.402
2019 Lessov-Schlaggar CN, Del Rosario OL, Morris JC, Ances BM, Schlaggar BL, Constantino JN. Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome. Journal of Neurodevelopmental Disorders. 11: 39. PMID 31842726 DOI: 10.1186/S11689-019-9300-2  0.378
2019 Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, et al. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease. Jama Network Open. 2: e1917126. PMID 31825500 DOI: 10.1001/jamanetworkopen.2019.17126  0.535
2019 Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Morris JC, Balota DA. The Relation Between Personality and Biomarkers in Sensitivity and Conversion to Alzheimer-Type Dementia. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 31822309 DOI: 10.1017/S1355617719001358  0.436
2019 Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, ... ... Morris JC, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet. Neurology. PMID 31810826 DOI: 10.1016/S1474-4422(19)30394-1  0.325
2019 Carr DB, Stowe JD, Morris JC. Driving in the elderly in health and disease. Handbook of Clinical Neurology. 167: 563-573. PMID 31753155 DOI: 10.1016/B978-0-12-804766-8.00031-5  0.364
2019 Morris GM, Holden TR, Weng H, Xiong C, Coble DW, Cairns NJ, Morris JC. Comparative Performance and Neuropathologic Validation of the AD8 Dementia Screening Instrument. Alzheimer Disease and Associated Disorders. PMID 31725472 DOI: 10.1097/Wad.0000000000000362  0.416
2019 Day GS, Cruchaga C, Wingo T, Schindler SE, Coble D, Morris JC. Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia. Jama Network Open. 2: e1913491. PMID 31617930 DOI: 10.1001/jamanetworkopen.2019.13491  0.318
2019 Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Tammie BLS, Morris JC, Xu J. The Interactions of Dopamine and Oxidative Damage in the Striatum of Neurodegenerative Diseases Patients. Journal of Neurochemistry. PMID 31613384 DOI: 10.1111/Jnc.14898  0.338
2019 Dube U, Del-Aguila JL, Li Z, Budde JP, Jiang S, Hsu S, Ibanez L, Fernandez MV, Farias F, Norton J, Gentsch J, Wang F, Salloway S, Masters CL, ... ... Morris JC, et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nature Neuroscience. PMID 31591557 DOI: 10.1038/S41593-019-0501-5  0.409
2019 Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, ... ... Morris JC, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955  0.464
2019 Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Ances BM, Duchek JM, Balota DA, Benzinger TLS. Association between personality and tau-PET binding in cognitively normal older adults. Brain Imaging and Behavior. PMID 31486975 DOI: 10.1007/S11682-019-00163-Y  0.594
2019 Li Z, Farias FHG, Dube U, Del-Aguila JL, Mihindukulasuriya KA, Fernandez MV, Ibanez L, Budde JP, Wang F, Lake AM, Deming Y, Perez J, Yang C, Bahena JA, Qin W, ... ... Morris JC, et al. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathologica. PMID 31456032 DOI: 10.1007/S00401-019-02066-0  0.352
2019 Carpenter CR, McFarland F, Avidan M, Berger M, Inouye SK, Karlawish J, Lin FR, Marcantonio E, Morris JC, Reuben DB, Shah RC, Whitson HE, Asthana S, Verghese J. Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series. Journal of the American Geriatrics Society. PMID 31436318 DOI: 10.1111/Jgs.16093  0.323
2019 Xu J, Sun J, Perrin RJ, Mach RH, Bales KR, Morris JC, Benzinger TLS, Holtzman DM. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains. Annals of Clinical and Translational Neurology. 6: 1423-1434. PMID 31402620 DOI: 10.1002/Acn3.50837  0.437
2019 Del-Aguila JL, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Fernandez MV, Ibanez L, Bradley J, Wang F, Bergmann K, Davenport R, Morris JC, Holtzman DM, Perrin RJ, Benitez BA, et al. A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain. Alzheimer's Research & Therapy. 11: 71. PMID 31399126 DOI: 10.1186/S13195-019-0524-X  0.4
2019 Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31378575 DOI: 10.1016/J.Jalz.2019.04.015  0.442
2019 Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. PMID 31371569 DOI: 10.1212/Wnl.0000000000008081  0.554
2019 Schultz A, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Grand Moursel L, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, et al. Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers. Annals of Neurology. PMID 31361916 DOI: 10.1002/Ana.25560  0.349
2019 Han F, Perrin RJ, Wang Q, Wang Y, Perlmutter JS, Morris JC, Benzinger TLS, Xu J. Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study. Parkinson's Disease. 2019: 7975407. PMID 31354934 DOI: 10.1155/2019/7975407  0.396
2019 Allison SL, Rodebaugh TL, Johnston C, Fagan AM, Morris JC, Head D. Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 31197326 DOI: 10.1093/Arclin/Acz019  0.367
2019 Thirunavu V, McCullough A, Su Y, Flores S, Dincer A, Morris JC, Cruchaga C, Benzinger TLS, Gordon BA. Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life. Journal of Alzheimer's Disease : Jad. PMID 31156169 DOI: 10.3233/Jad-190154  0.574
2019 Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Farias FHG, Fernández MV, Ibanez L, Jiang S, Perrin RJ, Cairns NJ, Morris JC, Harari O, Cruchaga C. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Molecular Neurodegeneration. 14: 18. PMID 31068200 DOI: 10.1186/S13024-019-0319-3  0.414
2019 Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, ... ... Morris JC, et al. Heritability and genetic variance of dementia with Lewy bodies. Neurobiology of Disease. PMID 30953760 DOI: 10.1016/J.Nbd.2019.04.004  0.348
2019 Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, Gordon BA, Su Y, Chen C, Shimony JS, Ances BM, Cairns NJ, Fagan AM, Morris JC, Benzinger TLS. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease. Neuroimage. Clinical. 22: 101767. PMID 30901713 DOI: 10.1016/J.Nicl.2019.101767  0.584
2019 Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Morris JC, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6  0.586
2019 Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, ... ... Morris JC, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30897203 DOI: 10.1093/Brain/Awz050  0.385
2019 Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, ... ... Morris JC, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 180-190. PMID 30847382 DOI: 10.1016/J.Dadm.2018.12.008  0.518
2019 Schindler SE, Li Y, Todd KW, Herries EM, Henson RL, Gray JD, Wang G, Graham DL, Shaw LM, Trojanowski JQ, Hassenstab JJ, Benzinger TLS, Cruchaga C, Jucker M, Levin J, ... ... Morris JC, et al. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30846386 DOI: 10.1016/J.Jalz.2018.12.019  0.41
2019 Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, Li QX, Collins SJ, Carlsson C, Asthana S, Masters CL, Johnson S, Morris JC, Albert M, Gross AL. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. PMID 30842300 DOI: 10.1212/Wnl.0000000000007248  0.322
2019 Ly CV, Koenig L, Christensen J, Gordon B, Beaumont H, Dahiya S, Chen J, Su Y, Nelson B, Jockel-Balsarotti J, Drain C, Jerome G, Morris JC, Fagan AM, Harms MB, et al. Tau positron emission tomography imaging in C9orf72 repeat expansion carriers. European Journal of Neurology. PMID 30790403 DOI: 10.1111/Ene.13940  0.532
2019 Wang G, Coble D, McDade EM, Hassenstab J, Fagan AM, Benzinger TLS, Bateman RJ, Morris JC, Xiong C. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30773445 DOI: 10.1016/J.Jalz.2018.12.008  0.427
2019 Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, ... ... Morris JC, et al. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology. PMID 30753379 DOI: 10.1093/Brain/Awz019  0.618
2019 Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM. The Structural Signature of Sporadic Creutzfeldt-Jakob Disease. European Journal of Neurology. PMID 30735286 DOI: 10.1111/Ene.13930  0.38
2019 Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, ... ... Morris JC, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3  0.589
2019 Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine. PMID 30643288 DOI: 10.1038/S41591-018-0297-Y  0.452
2019 Han JY, Besser LM, Xiong C, Kukull WA, Morris JC. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia. Alzheimer Disease and Associated Disorders. PMID 30633043 DOI: 10.1097/Wad.0000000000000291  0.439
2019 Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, Fagan AM, McCue L, Xiong C, Morris JC, Benzinger TLS, Holtzman DM. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease. Science Translational Medicine. 11. PMID 30626715 DOI: 10.1126/Scitranslmed.Aau6550  0.449
2019 Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM, Xiong C. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Jama Neurology. PMID 30615028 DOI: 10.1001/Jamaneurol.2018.4249  0.589
2019 Sinha N, Zhou A, Li Y, Joseph-Mathurin N, Xiong C, Morris J, Bateman R, Benzinger T, Cairns N, Adrc K, Dian. Stereologic measures of beta-amyloid load in postmortem autosomal dominant Alzheimer disease brain validate PiB-PET as a useful biomarker Canadian Journal of Neurological Sciences. 46. DOI: 10.1017/Cjn.2019.257  0.377
2019 Chen G, Gordon BA, Liu J, LaMontagne PJ, Keefe S, Dincer A, Morris JC, Benzinger TL. P1-246: BASELINE BIOMARKERS ARE MORE ACCURATE THAN LONGITUDINAL CHANGE OF BIOMARKERS IN PREDICTING COGNITIVE DECLINE Alzheimer's & Dementia. 15: P332-P333. DOI: 10.1016/J.Jalz.2019.06.801  0.533
2019 Strain JF, Wisch J, Kilgore CB, McDade E, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TLS, Bateman R, Ances BM, Dian. Ic‐P‐098: Phosphorylation Of Specific Tau Sites Is Associated With Loss Of White Matter Integrity In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4941  0.574
2019 Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. Ic-P-094: Cross-Sectional And Longitudinal Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4937  0.552
2019 Dincer A, Gordon BA, Vlassenko AG, Goyal MS, Aschenbrenner AJ, McCullough AA, Adedokun A, Marple LM, Flores S, Keefe S, Chen G, Hornbeck RC, Morris JC, Benzinger TL. IC-P-090: COMPARISON OF ALZHEIMER'S DISEASE BIOMARKER MEASURES AS PREDICTORS OF COGNITION Alzheimer's & Dementia. 15: P80-P80. DOI: 10.1016/J.Jalz.2019.06.4933  0.595
2019 Gonneaud J, Baria A, Binette AP, Benzinger TLS, Morris JC, Bateman R, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S. Ic-P-054: Prediction Of Brain Age Using Resting-State Functional Connectivity Reveals Accelerated Aging In The Preclinical Phase Of Autosomal Dominant Alzheimer'S Disease, Irrespectiveof Amyloid Pathology Alzheimers & Dementia. 15: 240. DOI: 10.1016/J.Jalz.2019.06.4897  0.376
2019 Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. O3-12-01: Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4690  0.553
2019 Wang G, Aschenbrenner AJ, Li Y, Mcdade E, Liu L, Benzinger TLS, Bateman R, Morris JC, Hassenstab J, Berry S, Xiong C. Two-Period Linear Mixed Effects Primary Analysis Model For Clinical Trials With Run-In Data For Alzheimer Disease Alzheimers & Dementia. 15: 217. DOI: 10.1016/J.Jalz.2019.06.4566  0.32
2019 Wang G, Lorenzi M, Li Y, Donohue MC, Mcdade E, Aschenbrenner AJ, Benzinger TL, Fagan AM, Schindler SE, Hassenstab J, Berry S, Morris JC, Xiong C, Bateman R. ESTIMATING YEARS FROM CLINICAL SYMPTOM ONSET FOR SPORADIC ALZHEIMER DISEASE: HOW FAR ARE WE? Alzheimer's & Dementia. 15: P216-P217. DOI: 10.1016/J.Jalz.2019.06.4565  0.332
2019 Li Y, Schindler SE, Llibre Guerra JJ, Bollinger JG, Ovod V, Mawuenyega KG, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM, Bateman R. PLASMA Aβ42/Aβ40 PREDICTS HIPPOCAMPAL ATROPHY Alzheimer's & Dementia. 15: P191-P192. DOI: 10.1016/J.Jalz.2019.06.4519  0.545
2019 Bateman R, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM. F2-07-01: BLOOD AMYLOID-BETA PREDICTS AMYLOID PET CONVERSION Alzheimer's & Dementia. 15: P526-P526. DOI: 10.1016/J.Jalz.2019.06.4440  0.522
2019 Joseph-Mathurin N, Perrin RJ, Cairns NJ, Franklin EE, Xiong C, Preboske GM, Jack CR, Morris JC, Bateman R, Benzinger TLS. Ic-P-046: Cerebral Amyloid Angiopathy Is More Severe In Autosomal Dominant Ad Cases With Cerebral Microhemorrhages: Results From The Dian Study Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4208  0.339
2019 Butt OH, Wisch J, Schindler SE, Fagan AM, Benzinger TL, Cruchaga C, Morris JC, Ances BM. IC-P-023: EARLY RESTING-STATE NETWORK DYSFUNCTION IN APOE ε4 CARRIERS WITHOUT BIOMARKER EVIDENCE OF ALZHEIMER'S DISEASE IS RELATED TO SUBCLINICAL TAU CHANGES Alzheimer's & Dementia. 15: P30-P31. DOI: 10.1016/J.Jalz.2019.06.4185  0.398
2019 Wisch J, Roe CM, Babulal GM, Schindler SE, Fagan AM, Benzinger TL, Morris JC, Ances BM. IC-P-021: LONGITUDINAL CHANGES IN FUNCTIONAL CONNECTIVITY IN CONVERSION TO SYMPTOMATIC AD Alzheimer's & Dementia. 15: P29-P29. DOI: 10.1016/J.Jalz.2019.06.4183  0.329
2019 Flores S, Gordon BA, Su Y, Christensen J, Dincer A, Adedokun A, Wang Q, Hornbeck RC, Morris JC, Benzinger TL. P4-268: QUANTIFYING OFF-TARGET SKULL BINDING IN TAU PET STUDIES USING A CT-BASED MASK Alzheimer's & Dementia. 15: P1384-P1385. DOI: 10.1016/J.Jalz.2019.06.3937  0.504
2019 Wang Q, Dincer A, McCullough AA, Hassenstab J, Gordon BA, Liu J, Morris JC, Benzinger TLS, Wang Y. P4-261: White Matter Vasogenic Edema And Its Association With Neuropsychological Measures In Alzheimer Disease Alzheimers & Dementia. 15: 149. DOI: 10.1016/J.Jalz.2019.06.3930  0.585
2019 Fernandez V, Del-Aguila JL, Li Z, Dube U, Davenport R, Bradley J, Mihindukulasuriya KA, Farias FH, Budde JP, Norton J, Gentsch J, Morris JC, Harari O, Cruchaga C. P4-106: INTEGRATIVE ANALYSIS POINTS TO AGFG2 AS A NOVEL PLAYER IN THE PATHOLOGY OF ALZHEIMER DISEASE Alzheimer's & Dementia. 15: P1315-P1316. DOI: 10.1016/J.Jalz.2019.06.3767  0.394
2019 Rajasekar G, Roe CM, Babulal GM, Stout SH, Fagan AM, Holtzman DM, Ances BM, Morris JC. P3-591: Examining The Association Between Intraindividual Means And Standard Deviations Of Reaction Time And Preclinical Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3628  0.364
2019 Vlassenko AG, Gordon BA, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME, Goyal MS. P3-407: PIB BINDING TOPOGRAPHY BEST CORRELATES WITH YOUNG ADULT GLYCOLYSIS Alzheimer's & Dementia. 15: P1109-P1110. DOI: 10.1016/J.Jalz.2019.06.3441  0.48
2019 Ringman JM, Coppola G, Joe EB, Bateman R, Morris JC, Benzinger TL, Chui HC. P3-182: AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE ARISING FROM A NOVEL TRUNCATION MUTATION IN PSEN1 Alzheimer's & Dementia. 15: P1000-P1000. DOI: 10.1016/J.Jalz.2019.06.3211  0.371
2019 Luckett PH, Morris JC, Benzinger TL, Ances BM. P3-075: MODELING FUNCTIONAL CONNECTIVITY CHANGES IN LATE ONSET ALZHEIMER'S DISEASE USING DEEP LEARNING Alzheimer's & Dementia. 15: P954-P955. DOI: 10.1016/J.Jalz.2019.06.3102  0.354
2019 Dincer A, Mehrotra V, Aschenbrenner AJ, McCullough AA, Duchek JM, Balota DA, Chen G, Hornbeck RC, Morris JC, Benzinger TL, Gordon BA. P2-412: PRECLINICAL AD PATHOLOGY PARTIALLY MEDIATES THE RELATIONSHIP BETWEEN CORTICAL THICKNESS AND ATTENTIONAL CONTROL Alzheimer's & Dementia. 15: P765-P766. DOI: 10.1016/J.Jalz.2019.06.2819  0.562
2018 Wang G, Xiong C, McDade EM, Hassenstab J, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Gordon BA, Morris JC, Li Y, Bateman RJ. Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 669-676. PMID 30569014 DOI: 10.1016/J.Trci.2018.10.009  0.611
2018 Bussy A, Snider BJ, Coble D, Xiong C, Fagan AM, Cruchaga C, Benzinger TLS, Gordon BA, Hassenstab J, Bateman RJ, Morris JC. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiology of Aging. 75: 42-50. PMID 30530186 DOI: 10.1016/J.Neurobiolaging.2018.10.011  0.602
2018 Javaherian K, Newman BM, Weng H, Hassenstab J, Xiong C, Coble D, Fagan AM, Benzinger T, Morris JC. Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Disease and Associated Disorders. PMID 30489279 DOI: 10.1097/Wad.0000000000000284  0.366
2018 Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, ... Morris JC, et al. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine. PMID 30482868 DOI: 10.15252/Emmm.201809712  0.493
2018 Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/S40478-018-0624-Z  0.471
2018 Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, ... ... Morris JC, et al. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiology of Aging. PMID 30448004 DOI: 10.1016/J.Neurobiolaging.2018.10.019  0.336
2018 Joseph-Mathurin N, Su Y, Blazey TM, Jasielec M, Vlassenko A, Friedrichsen K, Gordon BA, Hornbeck RC, Cash L, Ances BM, Veale T, Cash DM, Brickman AM, Buckles V, Cairns NJ, ... ... Morris JC, et al. Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 669-677. PMID 30417072 DOI: 10.1016/J.Dadm.2018.08.012  0.534
2018 Babulal GM, Chen S, Williams MM, Trani JF, Bakhshi P, Chao GL, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Morris JC, Roe CM. Depression and Alzheimer's Disease Biomarkers Predict Driving Decline. Journal of Alzheimer's Disease : Jad. PMID 30400098 DOI: 10.3233/Jad-180564  0.38
2018 Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J, Sweet RA, Rascovsky K, Teylan M, Beekly D, Thomas G, ... ... Morris JC, et al. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Disease and Associated Disorders. PMID 30376508 DOI: 10.1097/Wad.0000000000000279  0.334
2018 Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Tick-Chong MS, Amaral AC, Murray ME, Moulder KL, Morris JC, Cairns NJ, Parisi JE, Lowe VJ, Petersen RC, Kofler J, Ikonomovic MD, et al. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology. Neurobiology of Disease. PMID 30336198 DOI: 10.1016/J.Nbd.2018.10.009  0.402
2018 Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321505 DOI: 10.1016/J.Jalz.2018.08.005  0.457
2018 Roe CM, Ances BM, Head D, Babulal GM, Stout SH, Grant EA, Hassenstab J, Xiong C, Holtzman DM, Benzinger TLS, Schindler SE, Fagan AM, Morris JC. Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain : a Journal of Neurology. PMID 30304397 DOI: 10.1093/Brain/Awy244  0.365
2018 Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. Widespread distribution of tauopathy in preclinical Alzheimer's disease. Neurobiology of Aging. 72: 177-185. PMID 30292840 DOI: 10.1016/J.Neurobiolaging.2018.08.022  0.573
2018 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, ... ... Morris JC, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059  0.45
2018 Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98. PMID 30253800 DOI: 10.1186/S13195-018-0426-3  0.468
2018 Ihara R, Vincent BD, Baxter MR, Franklin EE, Hassenstab JJ, Xiong C, Morris JC, Cairns NJ. Relative neuron loss in hippocampal sclerosis of aging and Alzheimer disease. Annals of Neurology. PMID 30246887 DOI: 10.1002/Ana.25344  0.332
2018 Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30239611 DOI: 10.1093/Brain/Awy229  0.393
2018 Day GS, Musiek ES, Morris JC. Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Disease and Associated Disorders. PMID 30222606 DOI: 10.1097/Wad.0000000000000276  0.337
2018 McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277  0.606
2018 Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. PMID 30068637 DOI: 10.1212/Wnl.0000000000006075  0.582
2018 Karch CM, Hernández D, Wang JC, Marsh J, Hewitt AW, Hsu S, Norton J, Levitch D, Donahue T, Sigurdson W, Ghetti B, Farlow M, Chhatwal J, Berman S, Cruchaga C, ... Morris JC, et al. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network. Alzheimer's Research & Therapy. 10: 69. PMID 30045758 DOI: 10.1186/S13195-018-0400-0  0.378
2018 Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage. Clinical. 19: 406-416. PMID 30035025 DOI: 10.1016/J.Nicl.2018.04.022  0.519
2018 Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, et al. Discovery and validation of autosomal dominant Alzheimer's disease mutations. Alzheimer's Research & Therapy. 10: 67. PMID 30021643 DOI: 10.1186/S13195-018-0392-9  0.609
2018 Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, ... Morris JC, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/Ana.25299  0.44
2018 Strain JF, Smith RX, Beaumont H, Roe CM, Gordon BA, Mishra S, Adeyemo B, Christensen JJ, Su Y, Morris JC, Benzinger TLS, Ances BM. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology. PMID 29959265 DOI: 10.1212/Wnl.0000000000005864  0.598
2018 Li Z, Del-Aguila JL, Dube U, Budde J, Martinez R, Black K, Xiao Q, Cairns NJ, Dougherty JD, Lee JM, Morris JC, Bateman RJ, Karch CM, Cruchaga C, et al. Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Medicine. 10: 43. PMID 29880032 DOI: 10.1186/S13073-018-0551-4  0.416
2018 Roe CM, Babulal GM, Stout SH, Ott BR, Carr DB, Williams MM, Benzinger TLS, Fagan AM, Holtzman DM, Ances BM, Morris JC. Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel, Switzerland). 3. PMID 29805967 DOI: 10.3390/Geriatrics3020023  0.432
2018 Gordon BA, McCullough A, Mishra S, Blazey TM, Su Y, Christensen J, Dincer A, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TLS. Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 245-252. PMID 29780869 DOI: 10.1016/J.Dadm.2018.02.003  0.591
2018 Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Morris JC, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838  0.443
2018 Mishra S, Blazey TM, Holtzman DM, Cruchaga C, Su Y, Morris JC, Benzinger TLS, Gordon BA. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype. Brain : a Journal of Neurology. PMID 29672664 DOI: 10.1093/Brain/Awy103  0.577
2018 Vlassenko AG, Gordon BA, Goyal MS, Su Y, Blazey TM, Durbin TJ, Couture LE, Christensen JJ, Jafri H, Morris JC, Raichle ME, Benzinger TL. Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiology of Aging. 67: 95-98. PMID 29655050 DOI: 10.1016/J.Neurobiolaging.2018.03.014  0.573
2018 Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Morris JC, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009  0.43
2018 Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Fox NC, Schott JM, Alexander DC. Data-driven models of dominantly-inherited Alzheimer's disease progression. Brain : a Journal of Neurology. PMID 29579160 DOI: 10.1093/Brain/Awy050  0.409
2018 Allison S, Babulal GM, Stout SH, Barco PP, Carr DB, Fagan AM, Morris JC, Roe CM, Head D. Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities. Alzheimer Disease and Associated Disorders. PMID 29578861 DOI: 10.1097/Wad.0000000000000257  0.401
2018 Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Morris JC, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053  0.422
2018 Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Benzinger TLS, Holtzman DM, Morris JC, Fagan AM. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29501462 DOI: 10.1016/J.Jalz.2018.01.013  0.579
2018 Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. Jama Neurology. PMID 29482212 DOI: 10.1001/Jamaneurol.2017.5135  0.413
2018 Del-Aguila JL, Fernández MV, Schindler S, Ibanez L, Deming Y, Ma S, Saef B, Black K, Budde J, Norton J, Chasse R, Harari O, Goate A, Xiong C, ... Morris JC, et al. Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline. Journal of Alzheimer's Disease : Jad. 62: 745-756. PMID 29480181 DOI: 10.3233/Jad-170834  0.428
2018 Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29462334 DOI: 10.1093/Brain/Awy008  0.445
2018 Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, ... Morris JC, et al. In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology. PMID 29438042 DOI: 10.1212/Wnl.0000000000005064  0.55
2018 Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, ... ... Morris JC, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0  0.6
2018 Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS. Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. Jama Neurology. PMID 29379963 DOI: 10.1001/Jamaneurol.2017.4719  0.419
2018 Gabel M, Gooblar J, Roe CM, Selsor NJ, Morris JC. Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies. Alzheimer Disease and Associated Disorders. PMID 29351092 DOI: 10.1097/Wad.0000000000000244  0.397
2018 Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29328928 DOI: 10.1016/J.Jalz.2017.11.011  0.411
2018 Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, ... ... Morris JC, et al. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. The Lancet. Neurology. 17: 64-74. PMID 29263008 DOI: 10.1016/S1474-4422(17)30400-3  0.362
2018 Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, Kornhuber J, Morris JC, Fagan AM. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 55: 813-822. PMID 27792012 DOI: 10.3233/Jad-160722  0.45
2018 Fernandez MV, Budde JP, Del-Aguila JL, Ibanez L, Deming Y, Harari O, Li Z, Dube U, Norton J, Morris JC, Goate AM, Cruchaga C, Nia-Load, Ncrad. P2-105: Nomination Of Novel Candidate Genes For Familial Late Onset Alzheimer Disease After Evaluation Of Gene-Based Family-Based Methods Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.791  0.311
2018 Vöglein J, Paumier KL, Cairns NJ, Franklin EE, Perrin RJ, Xiong C, Jucker M, Bateman RJ, Danek A, Morris JC, Levin J. P1-497: Clinical Correlates Of Lewy Body Pathology In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.507  0.391
2018 Koenig LN, Keefe S, Marple LM, Blazey T, Gordon BA, Hassenstab J, Morris JC, Miller-Thomas M, Shimony JS, Benzinger TLS. P1-390: Volumetric-Based Diagnosis Of Alzheimer'S Disease Using A Super-Normal Cohort Of Aging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.398  0.585
2018 Gray JD, Sutphen CL, Henson RL, Orusakwe A, Traynham C, Vandijck M, Gailey R, Lawson J, Gordon BA, Benzinger TLS, Morris JC, Fagan AM. P1-290: Concordance Between In Vivo Amyloid Imaging And Csf Ab1-42 And Total Tau Measured By The Automated Lumipulse® G Assay Platform Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.296  0.542
2018 Caballero MAA, Park DC, Song Z, Levin J, Bateman RJ, Morris JC, Jucker M, Danek A, Yakushev I, Benzinger TLS, Ewers M, Dian. O4-04-05: Fiber-Tract-Specific Decline In White-Matter Integrity During The Adult Lifespan And Preclinical Alzheimer'S Disease: Results From The Dallas Lifespan Brain Study And Dian Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2931  0.326
2018 McDade E, Li Y, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Goate AM, Morris JC, Cash DM, Fox NC, Xiong C, Holtzman DM, Bateman RJ. O2-04-03: What Goes Up Must Come Down: Longitudinal Decline In Cerebrospinal Fluid Tau Peptides Is Associated With Progressive Cortical Atrophy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2659  0.518
2018 Morris JC, Weiner M, Beckett L, Buckles VD, Xiong C, Dian. O2-04-01: Comparing Biomarker Rates Of Change In Autosomal Dominant Versus Sporadic Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2657  0.358
2018 Hassenstab J, Aschenbrenner AJ, Balota DA, McDade E, Lim Y, Fagan AM, Benzinger TLS, Cruchaga C, Goate A, Morris JC, Bateman RJ. O1-04-03: Comparing Smartphone-Administered Cognitive Assessments With Conventional Tests And Biomarkers In Sporadic And Dominantly Inherited Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2350  0.366
2018 Gordon BA, Blazey T, Christensen J, Flores S, Dincer A, Keefe S, McDade E, Wang G, Raichle ME, Koeppe B, Jack CR, Morris JC, Bateman RJ, Benzinger TLS. The Relationship Between Tau Pet And Other Ad Biomarkers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2271  0.635
2018 Wang Q, Wang Y, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances BM, Morris JC, Benzinger TLS. Ic-P-195: Quantification Of White Matter Cellularity In Preclinical And Early Symptomatic Alzheimer Disease Using Neuro-Immnue Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2262  0.368
2018 Molteni E, Veale T, Altmann A, Cardoso MJ, Benzinger TLS, Jack CR, McDade E, Morris JC, Rossor MN, Ourselin S, Fox NC, Cash DM, Modat M. Ic-P-165: Robust Identification Of Brain Structures Most Discriminative In Detecting Early Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2232  0.362
2018 Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. IC-P-158: GENETIC AND ENVIRONMENTAL FACTORS ARE DIFFERENTIALLY RELATED TO Aβ BURDEN IN THE PRESYMPTOMATIC PHASE OF AUTOSOMAL DOMINANT AND SPORADIC ALZHEIMER'S DISEASE Alzheimers & Dementia. 14: 134. DOI: 10.1016/J.Jalz.2018.06.2225  0.371
2018 Franzmeier N, Ren J, Bateman RJ, Morris JC, Levin J, Yakushev I, Jucker M, Benzinger TLS, Ewers M, Investigators D. F5-05-03: The Bdnf Val66Met Snp Is Related To Hippocampal Connectivity And Cognitive Decline In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2132  0.364
2018 Strain JF, Tanenbaum A, Smith RX, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. Ic-P-043: Functional Architectural Differences Between Autosomal Dominant Alzheimer'S Disease And Late Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2107  0.603
2018 Smith RX, Tanenbaum A, Strain JF, Gordon BA, Fagan AM, Hassenstab J, McDade E, Xiong C, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM. P4-108: Resting-State Functional Connectivity Is Associated With Pathological Biomarkers In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2106  0.593
2018 Flores S, Su Y, Wang G, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Mintun MA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Bateman RJ, Benzinger TLS. Ic-P-009: Comparing The Centiloid Scale For Pittsburgh Compound B And Florbetapir In Longitudinal Pet Studies Of Sporadic Ad Alzheimers & Dementia. 14: 19. DOI: 10.1016/J.Jalz.2018.06.2073  0.54
2018 Schultz SA, Apel A, Preische O, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. Ic-04-02: Serum Neurofilament Light Chain Levels Are Associated With Cortical Thickness, Beta-Amyloid Burden, And Cerebral Glucose Metabolism In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2050  0.552
2018 Franzmeier N, Ren J, Bateman RJ, Morris JC, Levin J, Jucker M, Benzinger TLS, Yakushev I, Koutsouleris N, Ewers M, Investigators D. Ic-P-090: Cross-Validated Biomarker-Based Prediction Of 4-Year Rate Of Cognitive Decline In Non-Demented Subjects At Risk Of Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1789  0.343
2018 Babulal GM, Chen S, Williams MM, Trani J, Bakhshi P, Chao LG, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Morris JC, Ances BM, Roe CM. P3-319: Depression And Alzheimer Disease Biomarkers Predict Driving Decline Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1680  0.354
2018 Preische O, Schultz SA, Apel A, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. P3-251: Serum Neurofilament Light Chain Levels Are Associated With Csf Neurofilament Light Chain, Cognitive Status, And Disease Progression In Autosomal Dominant Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1611  0.549
2018 Aschenbrenner AJ, Hassenstab J, Wang G, McDade E, Balota DA, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ. P2-499: Alzheimer Disease Biomarkers Predict Differences In Personality: A Cross-Lagged Panel Analysis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1192  0.376
2018 Strain JF, Smith RX, Wang Q, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. P2-464: Biological Correlates Of White Matter Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1157  0.583
2018 Barthélemy NR, Li Y, Wang G, Fagan AM, Morris JC, Benzinger TLS, Goate A, Hassenstab J, Xiong C, Sato C, Bateman RJ, McDade E. P1-023: Mass Spectrometry-Based Measurement Of Longitudinal Csf Tau Identifies Different Phosphorylated Sites That Track Distinct Stages Of Presymptomatic Dominantly Inherited Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.024  0.338
2017 Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, Giordani B, Kramer J, Loewenstein D, Marson D, Mungas D, Salmon D, Welsh-Bohmer K, Zhou XH, Shirk SD, ... ... Morris JC, et al. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Disease and Associated Disorders. PMID 29240561 DOI: 10.1097/Wad.0000000000000223  0.42
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Morris JC, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.439
2017 Xiong C, Luo J, Chen L, Gao F, Liu J, Wang G, Bateman R, Morris JC. Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case-Application to the early diagnosis of Alzheimer disease. Statistical Methods in Medical Research. 962280217742539. PMID 29182052 DOI: 10.1177/0962280217742539  0.321
2017 Roe CM, Babulal GM, Mishra S, Gordon BA, Stout SH, Ott BR, Carr DB, Ances BM, Morris JC, Benzinger TLS. Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29171997 DOI: 10.3233/Jad-170521  0.599
2017 Fernández MV, Kim JH, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U, Harari O, Norton J, Chasse R, Morris JC, Goate A, et al. Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease. Plos Genetics. 13: e1007045. PMID 29091718 DOI: 10.1371/Journal.Pgen.1007045  0.419
2017 Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, ... ... Morris JC, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 549: 523-527. PMID 28959956 DOI: 10.1038/Nature24016  0.358
2017 Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J, Ibanez L, Kapoor M, Tosto G, Mayeux RP, Holtzman DM, Fagan AM, Morris JC, Bateman RJ, Goate AM, et al. Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28943286 DOI: 10.1016/J.Jalz.2017.08.013  0.426
2017 Moulder KL, Besser LM, Beekly D, Blennow K, Kukull W, Morris JC. Factors Influencing Successful Lumbar Puncture in Alzheimer Research. Alzheimer Disease and Associated Disorders. PMID 28891819 DOI: 10.1097/Wad.0000000000000209  0.344
2017 Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 5. PMID 28796161 DOI: 10.3390/Biomedicines5030046  0.323
2017 Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B. On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimer's Research & Therapy. 9: 60. PMID 28793924 DOI: 10.1186/S13195-017-0283-5  0.445
2017 Ringman JM, Casado M, Van Berlo V, Pa J, Joseph-Mathurin N, Fagan AM, Benzinger T, Bateman RJ, Morris JC. A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism. Neuroscience Letters. 657: 11-15. PMID 28764909 DOI: 10.1016/J.Neulet.2017.07.046  0.416
2017 Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, Hornbeck R, Balota DA, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. Neuroimage. PMID 28756238 DOI: 10.1016/J.Neuroimage.2017.07.050  0.602
2017 Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268  0.393
2017 Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, Sullivan M, Paumier K, Holtzman DM, Morris JC, Benzinger T, Fagan AM, Patterson BW, Bateman RJ. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28734653 DOI: 10.1016/J.Jalz.2017.06.2266  0.32
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Morris J, ... ... Morris JC, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.36
2017 Schindler SE, Sutphen CL, Teunissen C, McCue LM, Morris JC, Holtzman DM, Mulder SD, Scheltens P, Xiong C, Fagan AM. Upward drift in cerebrospinal fluid amyloid-β 42 assay values for more than 10 years. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28710906 DOI: 10.1016/J.Jalz.2017.06.2264  0.382
2017 Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003  0.401
2017 Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, ... ... Morris JC, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008  0.393
2017 Schindler SE, Jasielec MS, Weng H, Hassenstab JJ, Grober E, McCue LM, Morris JC, Holtzman DM, Xiong C, Fagan AM. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiology of Aging. 56: 25-32. PMID 28482211 DOI: 10.1016/J.Neurobiolaging.2017.04.004  0.393
2017 Lucey BP, Fagan AM, Holtzman DM, Morris JC, Bateman RJ. Diurnal oscillation of CSF Aβ and other AD biomarkers. Molecular Neurodegeneration. 12: 36. PMID 28478762 DOI: 10.1186/S13024-017-0161-4  0.443
2017 Babulal GM, Stout SH, Head D, Holtzman DM, Fagan AM, Morris JC, Roe CM. Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report. Journal of Alzheimer's Disease : Jad. PMID 28453487 DOI: 10.3233/Jad-170067  0.427
2017 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, ... ... Morris JC, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W  0.356
2017 Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, ... ... Morris JC, et al. Preclinical Alzheimer's disease and longitudinal driving decline. Alzheimer's & Dementia (New York, N. Y.). 3: 74-82. PMID 28435853 DOI: 10.1016/J.Trci.2016.11.006  0.419
2017 Day GS, Gordon BA, Jackson K, Christensen JJ, Rosana Ponisio M, Su Y, Ances BM, Benzinger TL, Morris JC. Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. Alzheimer Disease and Associated Disorders. PMID 28394771 DOI: 10.1097/Wad.0000000000000196  0.601
2017 Babulal GM, Stout SH, Benzinger TL, Ott BR, Carr DB, Webb M, Traub CM, Addison A, Morris JC, Warren DK, Roe CM. A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease. Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society. 733464817690679. PMID 28380718 DOI: 10.1177/0733464817690679  0.398
2017 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28342697 DOI: 10.1016/J.Jalz.2016.11.007  0.383
2017 Day GS, Lim TS, Hassenstab J, Goate AM, Grant EA, Roe CM, Cairns NJ, Morris JC. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology. PMID 28235814 DOI: 10.1212/Wnl.0000000000003770  0.444
2017 Millar PR, Balota DA, Maddox GB, Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TL, Morris JC. Process Dissociation Analyses of Memory Changes in Healthy Aging, Preclinical, and Very Mild Alzheimer Disease: Evidence for Isolated Recollection Deficits. Neuropsychology. PMID 28206782 DOI: 10.1037/Neu0000352  0.424
2017 Gangishetti U, Perrin RJ, Arnold SE, Fagan AM, Morris JC, Trojanowski JQ, Hu WT. VALIDATING NON-AMYLOID, NON-TAU CSF BIOMARKERS FOR ALZHEIMER'S DISEASE IN THE PRE-SYMPTOMATIC, MCI, AND DEMENTIA STAGES: A MULTI-CENTER STUDY Alzheimer's & Dementia. 13: P1513-P1514. DOI: 10.1016/J.Jalz.2017.07.632  0.431
2017 Roe CM, Benzinger TLS, Fagan AM, Head DM, Ances B, Babulal GM, Stout SH, Grant EA, Holtzman DM, Morris JC. Prediction Of Incident Dementia: Longitudinal Biomarker And Clinical Changes Before And After Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.624  0.305
2017 Bos I, Vos SJ, Hassenstab J, Xiong C, Grant EA, Visser PJ, Morris JC, Fagan AM. ASSOCIATIONS BETWEEN VASCULAR RISK FACTORS AND AD BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 13: P1506-P1507. DOI: 10.1016/J.Jalz.2017.07.621  0.334
2017 Xiong C, McCue L, Grant EA, Bateman RJ, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC. CROSS-SECTIONAL AND LONGITUDINAL COMPARISONS OF COGNITION AND BIOMARKERS AMONG COGNITIVELY NORMAL INDIVIDUALS AGED 42 TO 65 YEARS WITH A FAMILY HISTORY OF EITHER AUTOSOMAL DOMINANT AD (ADAD) OR LATE-ONSET AD (LOAD) Alzheimer's & Dementia. 13: P923. DOI: 10.1016/J.Jalz.2017.07.357  0.352
2017 Aschenbrenner AJ, Hassenstab J, Gordon BA, Benzinger TL, Morris JC. NEUROIMAGING BIOMARKERS OF THE A/T/N CLASSIFICATION SYSTEM PREDICT CROSS-SECTIONAL AND LONGITUDINAL CHANGE IN PRECLINICAL AND EARLY ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P911. DOI: 10.1016/J.Jalz.2017.07.332  0.546
2017 McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265  0.596
2017 Cairns NJ, Perrin RJ, Vincent BD, Baxter MR, Franklin EE, Bateman RJ, Morris JC. NEUROPATHOLOGIC HETEROGENEITY IN FAMILIAL AND LATE-ONSET ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P877. DOI: 10.1016/J.Jalz.2017.07.255  0.387
2017 Fagan AM, Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Buckles VD, Benzinger TL, Morris JC. CONCORDANCE BETWEEN CSF AD BIOMARKERS MEASURED BY THE AUTOMATED ELECSYS ASSAY AND IN VIVO AMYLOID IMAGING Alzheimer's & Dementia. 13: P561. DOI: 10.1016/J.Jalz.2017.07.169  0.564
2017 Morris JC, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Grant EA, McCue L, Moulder KL, Schindler SE, Xiong C. RACIAL DIFFERENCES AND SIMILARITIES IN MOLECULAR BIOMARKERS FOR AD Alzheimer's & Dementia. 13: P560-P561. DOI: 10.1016/J.Jalz.2017.07.168  0.552
2017 Roe CM, Babulal GM, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Ott BR, Carr DB, Xiong C, Morris JC. Impact Of Cognitive Reserve And Preclinical Ad On Longitudinal Driving Performance Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.147  0.339
2017 Deming Y, Kapoor M, Li Z, Harari O, Black K, Del-Aguila JL, Carrell D, Cai Y, Fernandez MV, Budde JP, Ma S, Saef B, Howells B, Huang K, Bertelsen S, ... ... Morris JC, et al. CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P218-P219. DOI: 10.1016/J.Jalz.2017.07.096  0.386
2017 Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043  0.351
2017 Xiong C, Wang G, Coble D, Fague S, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC, Bateman RJ. [P2-209]: QUANTIFYING PRECLINICAL STAGES OF AUTOSOMAL DOMINANT ALZHEIMER DISEASE (ADAD) AND THE ASSOCIATED OVERALL BIOMARKER SIGNATURE ACROSS MODALITIES USING THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) Alzheimer's & Dementia. 13: P689-P690. DOI: 10.1016/J.Jalz.2017.06.861  0.412
2017 Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Benzinger TLS, Maruff P, Masters CL, McDade E, Morris JC, Bateman RJ. Bdnf Val66Met Increases Rate Of Memory Decline, Hippocampal Volume Loss And Tau Accumulation In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.283  0.31
2017 Mishra S, Gordon BA, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TL. RELATIONSHIP BETWEEN TAU POSITRON EMISSION TOMOGRAPHY WITH [18F]-AV-1451 AND LONGITUDINAL CORTICAL ATROPHY IN ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P233-P234. DOI: 10.1016/J.Jalz.2017.06.2627  0.569
2017 Vlassenko AG, Gordon BA, Goyal MS, Su Y, Jackson K, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME. BRAIN AEROBIC GLYCOLYSIS AND TAU DEPOSITION WITH [18F]-AV-1451 PET Alzheimer's & Dementia. 13: P922. DOI: 10.1016/J.Jalz.2017.06.2581  0.515
2017 Schultz SA, Gordon BA, Mishra S, Morris JC, Duchek JM, Balota DA, Benzinger TL, Ances B. THE ASSOCIATION BETWEEN PERSONALITY AND TAU PET DEPOSITION IN COGNITIVELY NORMAL OLDER ADULTS: FINDINGS FROM THE KNIGHT ALZHEIMER DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P145-P146. DOI: 10.1016/J.Jalz.2017.06.2572  0.57
2017 Day GS, Gordon BA, Perrin RJ, Cairns NJ, Schwetye KE, Ferguson CJ, Sinha N, Ponisio MR, Vincent BD, Beaumont H, Bucelli RC, Ghoshal N, Musiek ES, Morris JC, Benzinger TL, et al. FLORTAUCIPIR TAU-PET SPECIFICITY IS MAINTAINED IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CREUTZFELDT-JAKOB DISEASE Alzheimer's & Dementia. 13: P900-P901. DOI: 10.1016/J.Jalz.2017.06.2555  0.572
2017 Yablonskiy DA, Zhao Y, Cairns NJ, Hassenstab J, Benzinger TL, Astafiev SV, Wen J, Raichle ME, Morris JC. [IC-P-169]: GRADIENT ECHO PLURAL CONTRAST MRI PROVIDES NEW SURROGATE MARKERS OF BRAIN PATHOLOGY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P127-P128. DOI: 10.1016/J.Jalz.2017.06.2544  0.384
2017 Hari-Raj A, Dincer A, Gordon BA, Su Y, Ances BM, Morris JC, Bateman RJ, Benzinger TL. CORTICAL THINNING PATTERN IN AUTOSOMAL DOMINANT AD PREDICTS AMYLOID POSITIVITY IN SPORADIC AD Alzheimer's & Dementia. 13: P184-P185. DOI: 10.1016/J.Jalz.2017.06.2412  0.561
2017 Vlassenko AG, Gordon BA, Goyal MS, Su Y, Durbin TJ, Couture LE, Holtzman DM, Morris JC, Fagan AM, Benzinger TL, Bateman RJ, Raichle ME. [IC-P-064]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P53-P53. DOI: 10.1016/J.Jalz.2017.06.2337  0.575
2017 Mishra S, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Cruchaga C, Morris JC, Ances BM, Benzinger TL, Gordon BA. [IC-P-061]: APOE4 EFFECT ON LONGITUDINAL VOLUMETRICS AND PIB ACCUMULATION IN PRECLINICAL ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P50-P50. DOI: 10.1016/J.Jalz.2017.06.2334  0.582
2017 Joseph-Mathurin N, Kantarci K, Jack CR, Ringman JM, Salloway S, McDade E, Clifford D, Blazey T, Friedrichsen KA, Su Y, Gordon BA, Hornbeck RC, Mills S, Ances BM, Raichle ME, ... ... Morris JC, et al. Clinical Risk Related To Cerebral Microhemorrhages In Autosomal Dominant Alzheimer’S Disease: Longitudinal Results From The Dian Study Alzheimers & Dementia. 13: 47. DOI: 10.1016/J.Jalz.2017.06.2330  0.529
2017 Gordon BA, Blazey T, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Fagan AM, Marcus DS, Jack CR, ... ... Morris JC, et al. [IC-P-054]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: RESULTS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK Alzheimer's & Dementia. 13: P44-P45. DOI: 10.1016/J.Jalz.2017.06.2327  0.587
2017 Strain JF, Smith R, Beaumont H, Gordon BA, Mishra S, Christensen J, Morris JC, Benzinger TL, Ances BM. [P4-244]: WHITE MATTER INTEGRITY REFLECTS TAU ACCUMULATION IN AD-DEFINED REGIONS Alzheimer's & Dementia. 13: P1370-P1371. DOI: 10.1016/J.Jalz.2017.06.2112  0.564
2017 Babulal GM, Stout SH, Head DM, Holtzman DM, Fagan AM, Morris JC, Roe CM. [P4-185]: NEUROPSYCHIATRIC SYMPTOMS AND ALZHEIMER DISEASE BIOMARKERS PREDICT DRIVING DECLINE Alzheimer's & Dementia. 13: P1335-P1335. DOI: 10.1016/J.Jalz.2017.06.2052  0.373
2017 Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving Cessation Over A 22-Year Period: Dementia Severity And Csf Biomarkers Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1811  0.315
2017 Han J, Besser LM, Xiong C, Kukull WA, Morris JC. [P3-291]: CHOLINESTERASE INHIBITOR USE AND COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P1054-P1054. DOI: 10.1016/J.Jalz.2017.06.1505  0.362
2017 Day GS, Cruchaga C, Wingo T, Morris JC. [P3-257]: DECODING VARIABILITY IN AGE-AT-SYMPTOMATIC-ONSET BETWEEN PARENTS AND CHILDREN WITH SPORADIC ALZHEIMER DISEASE DEMENTIA Alzheimer's & Dementia. 13: P1041-P1042. DOI: 10.1016/J.Jalz.2017.06.1471  0.361
2017 Schindler SE, Herries EM, Ladenson JH, Morris JC, Fagan AM. Emerging Csf Biomarkers As Predictors Of Alzheimer Disease Dementia Alzheimers & Dementia. 13: 1014. DOI: 10.1016/J.Jalz.2017.06.1418  0.424
2017 Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Benzinger TL, Ances B. TAU DISTRIBUTION IN PRECLINICAL ALZHEIMER’s DISEASE: FINDINGS FROM THE KNIGHT ALZHEIMER’S DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P144-P145. DOI: 10.1016/J.Jalz.2017.06.1029  0.56
2017 Joseph-Mathurin N, Su Y, Blazey T, Jasielec MS, Vlassenko AG, Friedrichsen KA, Gordon BA, Hornbeck RC, Cash L, Ances BM, Raichle ME, Brickman AM, Buckles V, Cairns NJ, Cruchaga C, ... ... Morris JC, et al. Utility Of Perfusion Pet Models As Measures Of Neurodegeneration In An Autosomal Dominant Alzheimer’S Disease Population: Report From The Dian Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1027  0.529
2016 Lucey BP, Mawuenyega KG, Patterson BW, Elbert DL, Ovod V, Kasten T, Morris JC, Bateman RJ. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System. Jama Neurology. PMID 27992627 DOI: 10.1001/Jamaneurol.2016.4202  0.312
2016 Babulal GM, Traub CM, Webb M, Stout SH, Addison A, Carr DB, Ott BR, Morris JC, Roe CM. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology. F1000research. 5: 2376. PMID 27990264 DOI: 10.12688/F1000Research.9608.2  0.304
2016 Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. In vivo Detection of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease with Magnetic Resonance Imaging. Neuroimage. PMID 27989773 DOI: 10.1016/J.Neuroimage.2016.12.026  0.402
2016 Suárez-Calvet M, Araque Caballero MÁ, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Ewers M, Haass C. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Science Translational Medicine. 8: 369ra178. PMID 27974666 DOI: 10.1126/Scitranslmed.Aag1767  0.42
2016 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, et al. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27931796 DOI: 10.1016/J.Jalz.2016.10.006  0.41
2016 Head D, Allison S, Lucena N, Hassenstab J, Morris JC. Latent structure of cognitive performance in the adult children study. Journal of Clinical and Experimental Neuropsychology. 1-16. PMID 27868476 DOI: 10.1080/13803395.2016.1252725  0.426
2016 Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Ellingson SR, Morris JC, Goate AM, Kukull WA. Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology. Alzheimer Disease and Associated Disorders. PMID 27849641 DOI: 10.1097/Wad.0000000000000179  0.407
2016 Deming Y, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez MV, Budde J, Ma S, Saef B, Howells B, Bertelsen S, Huang KL, Sutphen CL, Tarawneh R, Fagan AM, ... ... Morris JC, et al. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40. Bmc Neurology. 16: 217. PMID 27832767 DOI: 10.1186/S12883-016-0742-9  0.401
2016 Baker-Nigh AT, Mawuenyega KG, Bollinger JG, Ovod V, Kasten T, Franklin EE, Liao F, Jiang H, Holtzman D, Cairns NJ, Morris JC, Bateman RJ. Human Central Nervous System (CNS) ApoE Isoforms are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared to Plasma. The Journal of Biological Chemistry. PMID 27793990 DOI: 10.1074/Jbc.M116.721779  0.39
2016 Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiology of Aging. PMID 27793474 DOI: 10.1016/J.Neurobiolaging.2016.09.020  0.583
2016 Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Morris JC, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0  0.385
2016 Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, ... ... Morris JC, et al. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiology of Aging. PMID 27666590 DOI: 10.1016/J.Neurobiolaging.2016.08.023  0.336
2016 Fernández MV, Black K, Carrell D, Saef B, Budde J, Deming Y, Howells B, Del-Aguila JL, Ma S, Bi C, Norton J, Chasse R, Morris J, Goate A, Cruchaga C, et al. SORL1 variants across Alzheimer's disease European American cohorts. European Journal of Human Genetics : Ejhg. PMID 27650968 DOI: 10.1038/Ejhg.2016.122  0.384
2016 Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P. Drug development in Alzheimer's disease: the path to 2025. Alzheimer's Research & Therapy. 8: 39. PMID 27646601 DOI: 10.1186/S13195-016-0207-9  0.409
2016 Gordon BA, Blazey T, Su Y, Fagan AM, Holtzman DM, Morris JC, Benzinger TL. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Jama Neurology. PMID 27548756 DOI: 10.1001/Jamaneurol.2016.2642  0.601
2016 Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, ... ... Morris JC, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/Brain/Aww200  0.439
2016 Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. Jama Neurology. PMID 27454922 DOI: 10.1001/Jamaneurol.2016.2078  0.456
2016 Day GS, Musiek ES, Roe CM, Norton J, Goate AM, Cruchaga C, Cairns NJ, Morris JC. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study. Jama Neurology. PMID 27454811 DOI: 10.1016/J.Jalz.2016.06.1371  0.429
2016 Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TL, Fagan AM, Morris JC, Roe CM. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27426238 DOI: 10.1016/J.Jagp.2016.04.004  0.461
2016 Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM. Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease. Annals of Neurology. PMID 27398953 DOI: 10.1002/Ana.24719  0.603
2016 Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078  0.362
2016 Vos SJ, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, Fagan AM, Benzinger TL. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiology of Aging. 44: 1-8. PMID 27318129 DOI: 10.1016/J.Neurobiolaging.2016.03.025  0.59
2016 Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain : a Journal of Neurology. PMID 27286736 DOI: 10.1093/Brain/Aww139  0.602
2016 Hassenstab J, Chasse R, Grabow P, Benzinger TL, Fagan AM, Xiong C, Jasielec M, Grant E, Morris JC. Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning. Neurobiology of Aging. 43: 23-33. PMID 27255812 DOI: 10.1016/J.Neurobiolaging.2016.03.014  0.379
2016 Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine. 8: 338ra66. PMID 27169802 DOI: 10.1126/Scitranslmed.Aaf2362  0.621
2016 Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, ... ... Morris JC, et al. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Disease and Associated Disorders. PMID 27128959 DOI: 10.1097/Wad.0000000000000154  0.461
2016 Ingber AP, Hassenstab J, Fagan AM, Benzinger TL, Grant EA, Holtzman DM, Morris JC, Roe CM. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27104893 DOI: 10.3233/Jad-150478  0.415
2016 Tarawneh R, D'Angelo G, Crimmins D, Herries E, Griest T, Fagan AM, Zipfel GJ, Ladenson JH, Morris JC, Holtzman DM. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease. Jama Neurology. PMID 27018940 DOI: 10.1001/Jamaneurol.2016.0086  0.39
2016 Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Morris JC, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647  0.444
2016 Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Morris JC, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082  0.407
2016 Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study. Neurology. PMID 27009258 DOI: 10.1212/Wnl.0000000000002593  0.416
2016 Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish J. Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26988427 DOI: 10.1016/J.Jalz.2016.01.009  0.337
2016 Allison SL, Fagan AM, Morris JC, Head D. Spatial Navigation in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967209 DOI: 10.3233/Jad-150855  0.428
2016 Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, ... Morris JC, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948  0.372
2016 Brier MR, McCarthy JE, Benzinger TL, Stern A, Su Y, Friedrichsen KA, Morris JC, Ances BM, Vlassenko AG. Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease. Neurobiology of Aging. 38: 104-11. PMID 26827648 DOI: 10.1016/J.Neurobiolaging.2015.10.025  0.454
2016 Day GS, Gordon BA, Benzinger TL, Morris JC. P4-337: IN VIVO Quantification of Regional TAU Deposition in Patients with Progressive Posterior Cortical Dysfunction Alzheimer's & Dementia. 12: P1163-P1164. DOI: 10.1016/J.Jalz.2016.07.081  0.532
2016 Petros J, Hassenstab J, Snitz BE, Zhou Y, Ringman JM, McDade E, Wang G, Balota DA, Aschenbrenner AJ, Benzinger TL, Cruchaga C, Fagan AM, Goate AM, Holtzman DM, Buckles V, ... ... Morris JC, et al. Dynamic Relationships Between “Big Five” Personality Traits, Alzheimer’S Disease Biomarkers, And Cognition In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.970  0.349
2016 McDade E, Weng H, Wang G, Xiong C, Fagan AM, Hassenstab J, Marcus DS, Morris JC, Benzinger TL, Cairns NJ, Goate AM, Buckles V, Holtzman DM, Berman S, Ghetti B, et al. O5-02-01: Longitudinal Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease: The Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 12: P378-P379. DOI: 10.1016/J.Jalz.2016.06.710  0.39
2016 Benzinger TLS, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, et al. Tau Pet Imaging With Av-1451 In Autosomal Dominant Alzheimer'S Disease: Update From The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12: 378. DOI: 10.1016/J.Jalz.2016.06.709  0.604
2016 Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Lee Smith Benzinger T, Maruff P, Snyder PJ, Masters CL, Ricardo A, Chhatwal JP, Farlow MR, Graff-Radford NR, Laske C, Levin J, ... ... Morris JC, et al. F5-02-03: BDNF VAL66MET Moderates Cognitive Impairment, Neuronal Dysfunction and TAU in Preclinical Autosomal Dominant Alzheimer's Disease Alzheimer's & Dementia. 12: P369-P369. DOI: 10.1016/J.Jalz.2016.06.689  0.381
2016 Cash DM, Kinnunen KM, Weston PS, Ryan NS, Modat M, Bateman R, Morris JC, Ourselin S, Rossor MN, Benzinger TLS, Fox NC. Longitudinal Atrophy In Autosomal Dominant Ad And Sporadic Ad: Lessons From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.688  0.36
2016 Weninger S, Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman R, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo M. F4-03-01: Collaboration for Alzheimer's Prevention (CAP): Advancing the Evaluation of Preclinical Alzheimer's Disease Treatments Alzheimer's & Dementia. 12: P325-P326. DOI: 10.1016/J.Jalz.2016.06.596  0.39
2016 Deming Y, Harari O, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez V, Budde J, Ma S, Saef B, Bertelsen S, Kauwe J, Fagan AM, Holtzman DM, Morris JC, et al. Cerebrospinal Fluid Levels Of Amyloid Beta And Tau As Endophenotypes Reveal Novel Variants Potentially Informative For Alzheimer'S Disease Alzheimers & Dementia. 12: 252. DOI: 10.1016/J.Jalz.2016.06.452  0.379
2016 Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Alzheimer'S Disease: Results From The Dian Study Alzheimers & Dementia. 12: 246. DOI: 10.1016/J.Jalz.2016.06.440  0.56
2016 Lee S, Zimmerman ME, Viqar F, Narkhede A, Tosto G, Lee Smith Benzinger T, Marcus DS, Goate AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, ... ... Morris JC, et al. O2-03-02: are White Matter Hyperintensities a Core Feature of Alzheimer’s Disease or Just a Reflection of Amyloid Angiopathy? Evidence From the Dominantly Inherited Alzheimer Network (DIAN) Alzheimer's & Dementia. 12: P226-P226. DOI: 10.1016/J.Jalz.2016.06.406  0.356
2016 Gordon BA, Blazey T, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. O1-07-04: Longitudinal Amyloid Deposition and Hippocampal Volume in Suspected Non-Alzheimer Pathophysiology and Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P191-P191. DOI: 10.1016/J.Jalz.2016.06.332  0.596
2016 Friedrichsen KA, Ghoshal N, Joseph-Mathurin N, Mishra S, Su Y, Christensen J, Aldea P, McConathy J, Gordon BA, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-206: Similarities and Differences in Patterns of [F18]-Av-1451 And [F18]-FDG in Frontotemporal Dementia Alzheimer's & Dementia. 12: P147-P147. DOI: 10.1016/J.Jalz.2016.06.238  0.508
2016 Friedrichsen KA, Mishra S, Gordon BA, Ghoshal N, Su Y, Joseph-Mathurin N, Christensen J, Aldea P, McConathy J, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-204: Principal Component Analysis of [18F]-Av-1451 TAU PET in Alzheimer’s Disease and Frontotemporal Dementia Alzheimer's & Dementia. 12: P145-P146. DOI: 10.1016/J.Jalz.2016.06.236  0.566
2016 Wang Q, Wang Y, Christensen J, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Imaging Marker Of Neuroinflammation Predicts Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1076. DOI: 10.1016/J.Jalz.2016.06.2252  0.381
2016 Laske C, Preische O, Graeber S, Jucker M, Bateman R, Morris JC, Mueller S. Decreased Body Mass Index In The Preclinical Stage Of Alzheimer'S Disease: Evidence From The Dominantly Inherited Alzheimer Network Alzheimers & Dementia. 12: 1069. DOI: 10.1016/J.Jalz.2016.06.2236  0.374
2016 Roe CM, Head DM, Babulal GM, Stout SH, Ghoshal N, Vernon EK, Selsor N, Fierberg R, Shulman N, Johnson A, Fague MS, Xiong C, Grant EA, Campbell A, Holtzman DM, ... ... Morris JC, et al. P4-150: Preclinical Alzheimer’s Disease Predicts Longitudinal Onset of Driving Difficulties Among Cognitively Normal Persons Alzheimer's & Dementia. 12: P1071-P1071. DOI: 10.1016/J.Jalz.2016.06.2215  0.343
2016 Ances B, Brier MR, Gordon BA, Friedrichsen KA, McCarthy JE, Stern A, Christensen J, Owen CJ, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, et al. IC-P-179: TAU Imaging Relationships With Amyloid B Imaging, CSF TAU/AB42 , and Cognition in Alzheimer’s Disease Alzheimer's & Dementia. 12: P130-P131. DOI: 10.1016/J.Jalz.2016.06.210  0.576
2016 Wang Q, Wang Y, Shimony JS, Owen CJ, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Simultaneous Quantification Of White Matter Abnormalities And Vasogenic Edema In Early Alzheimer Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.203  0.378
2016 Wang Q, Wang Y, Christensen J, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Imaging Marker Of Neuroinflammation Predicts Disease Progression In Alzheimer Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.200  0.382
2016 Schwarz AJ, Gordon BA, Tanenbaum A, Morris JC, Benzinger TL, Ances B. P3-283: Functional Connectivity with Anterior Temporal Lobe Regions Ordered According to the Braak Progression Scheme Reveals Sequential Coupling to Default Mode and Then Sensory Networks Alzheimer's & Dementia. 12: P946-P946. DOI: 10.1016/J.Jalz.2016.06.1946  0.478
2016 Gross AL, Johnson SC, Clark LR, Resnick SM, Moghekar A, Masters CL, Maruff P, Hassenstab J, Morris JC, Soldan A, Albert MS. P3-205: Development and Validation of an Algorithm for Diagnosing Preclinical Alzheimer’s Disease Across Five Cohorts Alzheimer's & Dementia. 12: P902-P903. DOI: 10.1016/J.Jalz.2016.06.1867  0.301
2016 Fernández MV, Black K, Carrell D, Saef B, Budde J, Deming Y, Howells B, Del-Aguila JL, Ma S, Norton J, Chasse R, Morris JC, Goate A, Cruchaga C. Sorl1 Variants Across Alzheimer’S Disease Cohorts In European Americans Alzheimers & Dementia. 12: 857. DOI: 10.1016/J.Jalz.2016.06.1756  0.307
2016 Kim S, Nho K, Shen L, Franklin EE, Morris JC, Cairns NJ, Saykin AJ. Influence Of Parkinson’S Disease Candidate Genes On Lewy Body Pathology In Autopsy-Confirmed Alzheimer'S Disease Cases Alzheimers & Dementia. 12: 854. DOI: 10.1016/J.Jalz.2016.06.1748  0.384
2016 Cash DM, Ridgway GR, Kinnunen KM, Benzinger TLS, Wallon D, Jack CR, Bateman R, Morris JC, Rossor MN, Ourselin S, Fox NC. A Longitudinal Morphometric Study Of Familial Alzheimer’S Disease: Results From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.172  0.351
2016 Gordon BA, Xiong C, Holtzman DM, Fagan AM, Morris JC, Benzinger TL. IC-P-139: Critical Analysis of Biomarker Cutoffs in Alzheimer Disease Alzheimer's & Dementia. 12: P103-P104. DOI: 10.1016/J.Jalz.2016.06.169  0.578
2016 Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Ad: Results From The Dian Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.147  0.533
2016 Wang Q, Wang Y, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TL. White Matter Neuroinflammation In Preclinical Alzheimer Disease Can Be Quantified By Diffusion Basis Spectrum Imaging Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1025  0.336
2016 Gordon BA, Friedrichsen KA, Brier MR, Blazey T, Su Y, Christensen J, McConathy J, Aldea P, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances B, Benzinger TL. P1-263: Relating PET and CSF Measure of TAU Pathology Alzheimer's & Dementia. 12: P513-P514. DOI: 10.1016/J.Jalz.2016.06.1012  0.553
2016 Mishra S, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Aldea P, Cairns NJ, Morris JC, Ances B, Benzinger TL. IC-01-03: Classifying TAU Pet Positivity With [18F]-AV-1451 in Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P2-P3. DOI: 10.1016/J.Jalz.2016.06.063  0.573
2015 Benitez BA, Cairns NJ, Schmidt RE, Morris JC, Norton JB, Cruchaga C, Sands MS. Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss. Acta Neuropathologica Communications. 3: 73. PMID 26610600 DOI: 10.1186/S40478-015-0256-5  0.359
2015 Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, ... ... Morris JC, et al. Erratum: Early behavioural changes in familial Alzheimers disease in the Dominantly Inherited Alzheimer Network (Brain (2015) 138 (103645) (10.1093/brain/awv004)) Brain. 138. PMID 26598496 DOI: 10.1093/Brain/Awv210  0.353
2015 Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiology of Aging. PMID 26545630 DOI: 10.1016/J.Jalz.2015.07.374  0.421
2015 Gooblar J, Roe CM, Selsor NJ, Gabel MJ, Morris JC. Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. Jama Neurology. 1-7. PMID 26501506 DOI: 10.1001/Jamaneurol.2015.2875  0.369
2015 Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology. Journal of Neuropathology and Experimental Neurology. 74: 1086-92. PMID 26469250 DOI: 10.1097/Nen.0000000000000254  0.422
2015 Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger S. CAP-advancing the evaluation of preclinical Alzheimer disease treatments. Nature Reviews. Neurology. PMID 26416539 DOI: 10.1038/Nrneurol.2015.177  0.426
2015 Aschenbrenner AJ, Balota DA, Fagan AM, Duchek JM, Benzinger TL, Morris JC. Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study. Journal of the International Neuropsychological Society : Jins. 21: 573-83. PMID 26416094 DOI: 10.1017/S1355617715000776  0.411
2015 Kester MI, Teunissen CE, Sutphen C, Herries EM, Ladenson JH, Xiong C, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort. Alzheimer's Research & Therapy. 7: 59. PMID 26383836 DOI: 10.1186/S13195-015-0142-1  0.335
2015 Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. Jama Neurology. 1-7. PMID 26366630 DOI: 10.1001/Jamaneurol.2015.1867  0.323
2015 Morley JE, Morris JC, Berg-Weger M, Borson S, Carpenter BD, Del Campo N, Dubois B, Fargo K, Fitten LJ, Flaherty JH, Ganguli M, Grossberg GT, Malmstrom TK, Petersen RD, Rodriguez C, et al. Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference. Journal of the American Medical Directors Association. 16: 731-9. PMID 26315321 DOI: 10.1016/J.Jamda.2015.06.017  0.304
2015 Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Morris JC, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903  0.566
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 7: 50. PMID 26203303 DOI: 10.1186/S13195-015-0135-0  0.349
2015 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 865-84. PMID 26194320 DOI: 10.1016/J.Jalz.2015.04.005  0.468
2015 Franklin EE, Perrin RJ, Vincent B, Baxter M, Morris JC, Cairns NJ. Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 815-22. PMID 26194314 DOI: 10.1016/J.Jalz.2015.05.010  0.437
2015 Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study. Neuropsychology. PMID 26192539 DOI: 10.1037/Neu0000222  0.553
2015 Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, Darby HD, Vandijck ML, Ladenson JH, Morris JC, Holtzman DM, et al. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. Jama Neurology. 72: 1029-1042. PMID 26147946 DOI: 10.1001/Jamaneurol.2015.1285  0.469
2015 Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TL. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia. Neuroimage. Clinical. 8: 246-52. PMID 26106548 DOI: 10.1016/J.Nicl.2015.04.017  0.59
2015 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: e1-e120. PMID 26073027 DOI: 10.1016/J.Jalz.2014.11.001  0.484
2015 Patterson BW, Elbert DL, Mawuenyega KG, Kasten T, Ovod V, Ma S, Xiong C, Chott R, Yarasheski K, Sigurdson W, Zhang L, Goate A, Benzinger T, Morris JC, Holtzman D, et al. Age and amyloid effects on human CNS amyloid-beta kinetics. Annals of Neurology. PMID 26040676 DOI: 10.1002/Ana.24454  0.383
2015 Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of Practice Effects in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26011114 DOI: 10.1037/Neu0000208  0.433
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Morris JC, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.339
2015 Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC. Clinical Features of Alzheimer Disease With and Without Lewy Bodies. Jama Neurology. PMID 25985321 DOI: 10.1016/J.Jalz.2015.06.406  0.44
2015 Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 25964057 DOI: 10.1111/Neup.12205  0.444
2015 Laske C, Sohrabi HR, Jasielec MS, Müller S, Koehler NK, Gräber S, Förster S, Drzezga A, Mueller-Sarnowski F, Danek A, Jucker M, Bateman RJ, Buckles V, Saykin AJ, Martins RN, ... Morris JC, et al. Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study. Biomed Research International. 2015: 828120. PMID 25922840 DOI: 10.1155/2015/828120  0.372
2015 Tolea MI, Morris JC, Galvin JE. Trajectory of Mobility Decline by Type of Dementia. Alzheimer Disease and Associated Disorders. PMID 25886717 DOI: 10.1097/Wad.0000000000000091  0.356
2015 Tolea MI, Morris JC, Galvin JE. Longitudinal associations between physical and cognitive performance among community-dwelling older adults. Plos One. 10: e0122878. PMID 25875165 DOI: 10.1371/Journal.Pone.0122878  0.322
2015 Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. Jama Neurology. 72: 656-65. PMID 25867677 DOI: 10.1001/Jamaneurol.2015.0202  0.409
2015 Su Y, Blazey TM, Snyder AZ, Raichle ME, Hornbeck RC, Aldea P, Morris JC, Benzinger TL. Quantitative amyloid imaging using image-derived arterial input function. Plos One. 10: e0122920. PMID 25849581 DOI: 10.1371/Journal.Pone.0122920  0.309
2015 Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology. 84: 1254-60. PMID 25716355 DOI: 10.1212/Wnl.0000000000001401  0.492
2015 Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, Balota DA. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers. Neurobiology of Aging. 36: 1771-9. PMID 25708908 DOI: 10.1016/J.Neurobiolaging.2015.01.019  0.573
2015 Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, ... ... Morris JC, et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain : a Journal of Neurology. 138: 1036-45. PMID 25688083 DOI: 10.1093/Brain/Awv004  0.355
2015 Chatterjee P, Gupta VB, Fagan AM, Jasielec MS, Xiong C, Sohrabi HR, Dhaliwal S, Taddei K, Bourgeat P, Brown BM, Benzinger T, Bateman RJ, Morris JC, Martins RN. Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Current Alzheimer Research. 12: 157-64. PMID 25654503 DOI: 10.2174/1567205012666150204125732  0.401
2015 Masters MC, Morris JC, Roe CM. "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis. Neurology. 84: 617-22. PMID 25589671 DOI: 10.1212/Wnl.0000000000001238  0.346
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Morris JC, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157  0.433
2015 Ming J, Harms MP, Morris JC, Beg MF, Wang L. Integrated cortical structural marker for Alzheimer's disease. Neurobiology of Aging. 36: S53-9. PMID 25444604 DOI: 10.1016/J.Neurobiolaging.2014.03.042  0.36
2015 Hsu PJ, Shou H, Benzinger T, Marcus D, Durbin T, Morris JC, Sheline YI. Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss. Journal of Alzheimer's Disease : Jad. 45: 27-33. PMID 25428255 DOI: 10.3233/Jad-141743  0.416
2015 Shim YS, Yang DW, Roe CM, Coats MA, Benzinger TL, Xiong C, Galvin JE, Cairns NJ, Morris JC. Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dementia and Geriatric Cognitive Disorders. 39: 92-104. PMID 25401390 DOI: 10.1159/000366411  0.403
2015 Aschenbrenner AJ, Balota DA, Tse CS, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology. 29: 368-81. PMID 25222200 DOI: 10.1037/Neu0000133  0.437
2015 Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, ... ... Morris JC, et al. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 70-98. PMID 25022540 DOI: 10.1016/J.Jalz.2014.04.514  0.371
2015 Gooblar J, Carpenter BD, Coats MA, Morris JC, Snider BJ. The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 533-540.e2. PMID 25022536 DOI: 10.1016/J.Jalz.2014.04.517  0.392
2015 Hurth K, Tarawneh R, Ghoshal N, Benzinger TL, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ. Whipple's disease masquerades as dementia with Lewy bodies. Alzheimer Disease and Associated Disorders. 29: 85-9. PMID 23995819 DOI: 10.1097/Wad.0B013E3182A715Da  0.387
2015 Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study Neuropsychology. DOI: 10.1037/neu0000222  0.477
2015 Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TLS. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia Neuroimage: Clinical. 8: 246-252. DOI: 10.1016/j.nicl.2015.04.017  0.526
2015 Kester MI, Teunissen CE, Crimmins DL, Macy EM, Ladenson JH, Scheltens P, Flier WMvd, Morris JC, Holtzman DM, Fagan AM. Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease Alzheimers & Dementia. 11: 326. DOI: 10.1016/J.Jalz.2015.07.471  0.395
2015 Cairns NJ, Perrin RJ, Franklin EE, Vincent B, Carter D, Morris JC. O4-02-01: Age-related neuropathology helps distinguish autosomal dominant from late-onset Alzheimer disease Alzheimer's & Dementia. 11: P269-P269. DOI: 10.1016/J.Jalz.2015.07.351  0.36
2015 Perrin RJ, Weng H, Bales KR, Morris JC, Benzinger TL, Fagan AM, Xiong C, Holtzman DM. O3-14-03: Novel fluid biomarkers for brain amyloid and dementia risk in presymptomatic Alzheimer disease Alzheimer's & Dementia. 11: P255-P255. DOI: 10.1016/J.Jalz.2015.07.317  0.391
2015 Monsell SE, Hassenstab J, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.291  0.33
2015 Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague MS, Xiong C, Grant E, Campbell A, Holtzman DM, ... ... Morris JC, et al. P2-130: Amyloid imaging and cerebrospinal fluid biomarkers predict driving performance in preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P533-P534. DOI: 10.1016/J.Jalz.2015.06.668  0.403
2015 Day GS, Lim TS, Hassenstab J, Grant EA, Goate A, Morris JC, Cairns NJ. Differentiating corticobasal degeneration and Alzheimer disease by longitudinal clinical and cognitive features Alzheimers & Dementia. 11: 525. DOI: 10.1016/J.Jalz.2015.06.646  0.368
2015 Huff MJ, Balota DA, Aschenbrenner AJ, Duchek JM, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. P2-085: Task-switching errors show sensitivity to preclinical Alzheimer's disease biomarkers Alzheimer's & Dementia. 11: P516-P516. DOI: 10.1016/J.Jalz.2015.06.622  0.345
2015 Del-Aguila JL, Gross AL, Sutti S, Sherva R, Mukherjee S, Crane PK, Goate A, Morris JC, Green RC, Cruchaga C. Identification of genetic variants associated with Alzheimer's disease: Progression rate Alzheimers & Dementia. 11: 487. DOI: 10.1016/J.Jalz.2015.06.552  0.357
2015 Xiong C, Jasielec MS, Fagan AM, Benzinger TL, Head DM, Hassenstab J, Grant E, Buckles V, Moulder KL, Morris JC. P1-106: Longitudinal biomarker connectivity on middle-aged asymptomatic individuals and optimal design on prevention trials of Alzheimer's disease Alzheimer's & Dementia. 11: P379-P379. DOI: 10.1016/J.Jalz.2015.06.304  0.363
2015 Hassenstab J, Lim Y, Fagan AM, Ma S, Xiong C, Buckles V, Bateman R, Morris JC. CSF tau predicts working memory and global cognitive decline in autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 379. DOI: 10.1016/J.Jalz.2015.06.302  0.339
2015 Fleisher M, Jilakara B, Grant E, Morris JC, Snider BJ. P1-098: Utility and impact of cerebrospinal fluid studies on dementia diagnosis in a specialty dementia practice Alzheimer's & Dementia. 11: P376-P376. DOI: 10.1016/J.Jalz.2015.06.295  0.339
2015 Friedrichsen KA, Benzinger TLS, Joseph-Mathurin N, Fagan AM, Cairns NJ, Stevenson TA, Su Y, Christensen J, McConathy J, Gordon B, McFarlane S, Ances B, Morris JC. Patterns of tau binding in T807-PET imaging Alzheimers & Dementia. 11: 110. DOI: 10.1016/J.Jalz.2015.06.187  0.506
2015 Schindler SE, Jasielec MS, Xiong C, Fagan AM, Morris JC, Hassenstab J. P4-118: Neuropsychological determinants of stage 3 of preclinical Alzheimer disease Alzheimer's & Dementia. 11: P823-P823. DOI: 10.1016/J.Jalz.2015.06.1824  0.391
2015 Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Morris JC, Goate A, Kukull W. Genetic differences between symptomatic and asymptomatic persons with Alzheimer's disease neuropathologic change Alzheimers & Dementia. 11: 767. DOI: 10.1016/J.Jalz.2015.06.1711  0.365
2015 Brier MR, McCarthy JE, Benzinger TL, Su Y, Friedrichsen KA, Morris JC, Ances B, Vlassenko A. P3-167: Predicting and characterizing development of preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P693-P693. DOI: 10.1016/J.Jalz.2015.06.1538  0.395
2015 Wang Q, Wang Y, Shimony JS, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Diffusion tensor imaging detected neurodegeneration in preclinical Alzheimer disease Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1525  0.347
2015 Owen CJ, Gordon B, Brier MR, Wang L, Wang Q, Joseph-Mathurin N, Su Y, Vlassenko A, Blazey T, Speidel B, LaMontagne P, Marcus DS, Friedrichsen KA, Hornbeck RC, Jackson K, ... ... Morris JC, et al. IC-P-100: The ILP: A new tool for evaluating preclinical Alzheimer's disease using volumetric MRI in a single participant Alzheimer's & Dementia. 11: P68-P68. DOI: 10.1016/J.Jalz.2015.06.121  0.571
2015 Joseph-Mathurin N, Su Y, Vlassenko A, Couture L, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Cash L, Stevenson TA, Ances B, Xiong C, Buckles V, Moulder KL, Morris JC, et al. P3-132: Comparison of cerebral glucose metabolism 18 F-FDG, early frames of 11 C-PiB, and cerebral blood flow 15 O-H2 O in autosomal dominant Alzheimer's disease Alzheimer's & Dementia. 11: P674-P674. DOI: 10.1016/J.Jalz.2015.06.1000  0.304
2015 Joseph-Mathurin N, Tang M, Friedrichsen KA, Owen CJ, Su Y, Hornbeck RC, Stevenson TA, Cash L, Raichle ME, Gordon B, Preboske GM, Koeppe RA, Jack CR, Goate A, Cruchaga C, ... ... Morris JC, et al. Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence Alzheimers & Dementia. 11: 172. DOI: 10.1016/J.Jalz.2015.06.072  0.492
2015 Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TL. IC-P-021: Lower body mass index is associated with greater Alzheimer pathology in asymptomatic individuals Alzheimer's & Dementia. 11: P25-P25. DOI: 10.1016/J.Jalz.2015.06.041  0.571
2015 Gordon BA, Vos S, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. IC-P-020: Comparison of nia-aa preclinical Alzheimer's disease staging with CSF and neuroimaging biomarkers Alzheimer's & Dementia. 11: P24-P25. DOI: 10.1016/J.Jalz.2015.06.040  0.583
2015 Joseph-Mathurin N, Su Y, Vlassenko A, Jasielec MS, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Stevenson TA, Cash L, Xiong C, Ringman JM, Brickman AM, Koeppe RA, Ances B, ... ... Morris JC, et al. IC-03-02: Early frame of PiB and FDG in autosomal dominant Alzheimer's disease: Similarity, discrepancy, and clinical implication Alzheimer's & Dementia. 11: P8-P9. DOI: 10.1016/J.Jalz.2015.06.013  0.382
2014 Sheline YI, West T, Yarasheski K, Jasielec MS, Hettinger JC, Tripoli DL, Xiong C, Frederiksen C, Grzelak MV, Bateman RJ, Morris JC, Lee JM, Cirrito JR. Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice". Science Translational Medicine. 6: 268lr4. PMID 25540323 DOI: 10.1126/Scitranslmed.3010609  0.356
2014 Xiong C, Weng H, Bennett DA, Boyle PA, Shah RC, Fague S, Hall CB, Lipton RB, Morris JC. Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 43: 131-9. PMID 25376544 DOI: 10.1159/000365733  0.422
2014 Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, ... ... Morris JC, et al. Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. Plos Genetics. 10: e1004758. PMID 25340798 DOI: 10.1371/Journal.Pgen.1004758  0.414
2014 Brier MR, Thomas JB, Snyder AZ, Wang L, Fagan AM, Benzinger T, Morris JC, Ances BM. Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging. Neurology. 83: 1613-9. PMID 25261500 DOI: 10.1212/Wnl.0000000000000939  0.454
2014 Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports. 14: 499. PMID 25217249 DOI: 10.1007/S11910-014-0499-8  0.406
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Morris JC, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.359
2014 Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Morris JC, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654  0.412
2014 Monsell SE, Mock C, Hassenstab J, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology. Neurology. 83: 434-40. PMID 24951474 DOI: 10.1212/Wnl.0000000000000650  0.448
2014 Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, ... ... Morris JC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596  0.315
2014 Yang YH, Wang H, Lam L, Chan WC, Yu X, Li T, Wang WF, Chiu PY, Lin YT, Hu CJ, Fuh JL, Morris JC. Characteristics of Alzheimer's disease among patients in Taiwan, Hong Kong, and Beijing. Journal of Alzheimer's Disease : Jad. 42: 193-200. PMID 24840566 DOI: 10.3233/Jad-140174  0.403
2014 Wang L, Day J, Roe CM, Brier MR, Thomas JB, Benzinger TL, Morris JC, Ances BM. The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Alzheimer Disease and Associated Disorders. 28: 122-7. PMID 24830360 DOI: 10.1097/Wad.0B013E318299D096  0.361
2014 Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, et al. An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice. Science Translational Medicine. 6: 236re4. PMID 24828079 DOI: 10.1126/Scitranslmed.3008169  0.417
2014 Dobrowolska JA, Kasten T, Huang Y, Benzinger TL, Sigurdson W, Ovod V, Morris JC, Bateman RJ. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. Plos One. 9: e89998. PMID 24646516 DOI: 10.1371/Journal.Pone.0089998  0.374
2014 Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/Joim.12199  0.427
2014 Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, ... ... Morris JC, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901  0.475
2014 Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, Goate AM. Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. Biological Psychiatry. 75: 723-31. PMID 24548642 DOI: 10.1016/J.Biopsych.2013.11.032  0.423
2014 Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC, Gibbs JR, Bras J, Sassi C, Harari O, Bertelsen S, Lupton MK, Powell J, ... ... Morris JC, et al. Missense variant in TREML2 protects against Alzheimer's disease. Neurobiology of Aging. 35: 1510.e19-26. PMID 24439484 DOI: 10.1016/J.Neurobiolaging.2013.12.010  0.406
2014 Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, ... ... Morris JC, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature. 505: 550-4. PMID 24336208 DOI: 10.1038/Nature12825  0.364
2014 Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology. 28: 19-29. PMID 24219606 DOI: 10.1037/Neu0000030  0.387
2014 Brier MR, Thomas JB, Fagan AM, Hassenstab J, Holtzman DM, Benzinger TL, Morris JC, Ances BM. Functional connectivity and graph theory in preclinical Alzheimer's disease. Neurobiology of Aging. 35: 757-68. PMID 24216223 DOI: 10.1016/J.Neurobiolaging.2013.10.081  0.445
2014 Xiong C, Luo J, Gao F, Morris JC. Optimizing parameters in clinical trials with a randomized start or withdrawal design. Computational Statistics & Data Analysis. 69: 101-113. PMID 24159249 DOI: 10.1016/J.Csda.2013.07.013  0.319
2014 Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Disease and Associated Disorders. 28: 50-7. PMID 23739296 DOI: 10.1097/Wad.0B013E31829628D4  0.331
2014 Cairns N, Perrin RJ, Householder E, Carter D, Vincent B, Morris J. P1-318: NEUROPATHOLOGIC HETEROGENEITY IN ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) SUBJECTS Alzheimer's & Dementia. 10: P428-P428. DOI: 10.1016/J.Jalz.2014.05.559  0.403
2014 Aschenbrenner AJ, Balota DA, Tse C, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. P1-021: SYNERGISTIC AND MEDIATIONAL EFFECTS OF ALZHEIMER'S DISEASE BIOMARKERS ON A COGNITIVE MEASURE Alzheimer's & Dementia. 10: P311-P312. DOI: 10.1016/J.Jalz.2014.05.256  0.401
2014 Cash DM, Kinnunen KM, Leung KK, Ahsan L, Cardoso J, Modat M, Nicholas J, Malone I, Benzinger T, Jack CR, Thompson P, Saykin AJ, Sperling RR, Villemagne V, Weiner M, ... ... Morris J, et al. Longitudinal Rates Of Atrophy In Familial Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.112  0.37
2014 Risacher SL, West JD, Tallman EM, McDonald BC, Wang Y, Epperson F, Murrell J, Benzinger TL, Bateman R, Morris JC, Farlow MR, Ghetti BF, Saykin AJ. IC-P-094: ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON-AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS Alzheimer's & Dementia. 10: P53-P53. DOI: 10.1016/J.Jalz.2014.05.099  0.323
2014 Wang Q, Roe C, Hildebolt C, Christensen J, Brewer J, Ances B, Morris J, Benzinger T. Combining Pet And Volumetric Mri To Improve Diagnoses Of Alzheimer Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.064  0.392
2014 Ghetti BF, Newell KL, Abrahamson EE, Cairns NJ, Murrell JR, Oblak AL, Unverzagt FW, Farlow MR, Epperson F, Richardson R, Dupree B, Morris JC, Klunk WE, Saykin AJ, Risacher SL, et al. IC-P-032: COMPARATIVE ANALYSIS OF PIB IN VIVO WITH 6-CN-PIB AND Aβ-IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION Alzheimer's & Dementia. 10: P20-P21. DOI: 10.1016/J.Jalz.2014.05.036  0.378
2014 Vlassenko AG, Fagan AM, Jasielec MS, Su Y, Xiong C, Holtzman DM, Benzinger TL, Morris JC. IC-P-008: REGIONAL PIB DEPOSITION AND CSF Aβ42 LEVELS SEVERAL YEARS PRIOR TO AMYLOID POSITIVITY Alzheimer's & Dementia. 10: P11-P11. DOI: 10.1016/J.Jalz.2014.05.012  0.338
2014 Hassenstab J, Aschenbrenner A, Balota D, Dreyfus DM, Bateman R, Morris JC. O4-12-06: COGNITIVE PERFORMANCE IN THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN): BASELINE AND PRELIMINARY LONGITUDINAL FINDINGS Alzheimer's & Dementia. 10: P277-P277. DOI: 10.1016/J.Jalz.2014.04.456  0.334
2014 Ryman D, Morris J, Bateman R. Predicting Symptom Onset In Autosomal Dominant Alzheimer'S Disease: A Systematic Review And Meta-Analysis Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.299  0.34
2014 Morris JC, Weng J, Xiong C. S3-01-01: SCREENING FOR ALZHEIMER'S DISEASE IN COGNITIVELY NORMAL OLDER ADULTS: SUBJECTIVE COGNITIVE DECLINE VERSUS INFORMANT REPORT Alzheimer's & Dementia. 10: P200-P200. DOI: 10.1016/J.Jalz.2014.04.241  0.332
2013 Xiong C, van Belle G, Chen K, Tian L, Luo J, Gao F, Yan Y, Chen L, Morris JC, Crane P. Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease. Statistics in Biopharmaceutical Research. 5. PMID 24363827 DOI: 10.1080/19466315.2012.756662  0.385
2013 Toledo JB, Cairns NJ, Da X, Chen K, Carter D, Fleisher A, Householder E, Ayutyanont N, Roontiva A, Bauer RJ, Eisen P, Shaw LM, Davatzikos C, Weiner MW, Reiman EM, ... Morris JC, et al. Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathologica Communications. 1: 65. PMID 24252435 DOI: 10.1186/2051-5960-1-65  0.478
2013 Su Y, D'Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, Blazey TM, Christensen JJ, Vora S, Morris JC, Mintun MA, Benzinger TL. Quantitative analysis of PiB-PET with FreeSurfer ROIs. Plos One. 8: e73377. PMID 24223109 DOI: 10.1371/Journal.Pone.0073377  0.411
2013 Roe CM, Fagan AM, Grant EA, Holtzman DM, Morris JC. CSF biomarkers of Alzheimer disease: "noncognitive" outcomes. Neurology. 81: 2028-31. PMID 24212387 DOI: 10.1212/01.Wnl.0000436940.78152.05  0.439
2013 Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Morris JC, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110  0.383
2013 Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, Morris JC. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimer's Research & Therapy. 5: 48. PMID 24131566 DOI: 10.1186/Alzrt213  0.446
2013 Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, ... ... Morris JC, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/Wnl.0B013E3182A841C6  0.396
2013 Duchek JM, Balota DA, Thomas JB, Snyder AZ, Rich P, Benzinger TL, Fagan AM, Holtzman DM, Morris JC, Ances BM. Relationship between Stroop performance and resting state functional connectivity in cognitively normal older adults. Neuropsychology. 27: 516-28. PMID 24040929 DOI: 10.1037/A0033402  0.392
2013 Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, ... ... Morris JC, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Revue Neurologique. 169: 737-43. PMID 24016464 DOI: 10.1016/J.Neurol.2013.07.017  0.359
2013 Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet. Neurology. 12: 957-65. PMID 24012374 DOI: 10.1016/S1474-4422(13)70194-7  0.461
2013 Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, Bertelsen S, Chibnik L, Schneider JA, Bennett DA, Fagan AM, Holtzman D, Morris JC, et al. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers. Plos Genetics. 9: e1003685. PMID 23990795 DOI: 10.1371/Journal.Pgen.1003685  0.376
2013 Wang L, Brier MR, Snyder AZ, Thomas JB, Fagan AM, Xiong C, Benzinger TL, Holtzman DM, Morris JC, Ances BM. Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. Jama Neurology. 70: 1242-8. PMID 23959173 DOI: 10.1001/Jamaneurol.2013.3253  0.388
2013 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e111-94. PMID 23932184 DOI: 10.1016/j.jalz.2013.05.1769  0.379
2013 Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154  0.366
2013 Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, ... ... Morris JC, et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 81: 736-44. PMID 23884042 DOI: 10.1212/Wnl.0B013E3182A1Aafe  0.382
2013 Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC. Preclinical Alzheimer disease and risk of falls. Neurology. 81: 437-43. PMID 23803314 DOI: 10.1212/Wnl.0B013E31829D8599  0.46
2013 Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, Bateman RJ. Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Science Translational Medicine. 5: 189ra77. PMID 23761040 DOI: 10.1126/Scitranslmed.3005615  0.362
2013 Wilkins CH, Roe CM, Morris JC, Galvin JE. Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type. Journal of the American Geriatrics Society. 61: 1055-9. PMID 23647233 DOI: 10.1111/Jgs.12255  0.399
2013 Monsell SE, Mock C, Roe CM, Ghoshal N, Morris JC, Cairns NJ, Kukull W. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology. 80: 2121-9. PMID 23645594 DOI: 10.1212/Wnl.0B013E318295D7A1  0.447
2013 Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 80: 1784-91. PMID 23576620 DOI: 10.1212/Wnl.0B013E3182918Ca6  0.423
2013 Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, ... ... Morris JC, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 78: 256-68. PMID 23562540 DOI: 10.1016/J.Neuron.2013.02.026  0.401
2013 Bakkour A, Morris JC, Wolk DA, Dickerson BC. The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage. 76: 332-44. PMID 23507382 DOI: 10.1016/J.Neuroimage.2013.02.059  0.41
2013 Shim YS, Roe CM, Buckles VD, Morris JC. Clinicopathologic study of Alzheimer's disease: Alzheimer mimics. Journal of Alzheimer's Disease : Jad. 35: 799-811. PMID 23481687 DOI: 10.3233/Jad-121594  0.452
2013 Ju YE, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, Morris JC, Holtzman DM. Sleep quality and preclinical Alzheimer disease. Jama Neurology. 70: 587-93. PMID 23479184 DOI: 10.1001/Jamaneurol.2013.2334  0.314
2013 Dong Y, Pang WS, Lim LB, Yang YH, Morris JC, Hilal S, Venketasubramanian N, Chen CL. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting. Journal of Alzheimer's Disease : Jad. 35: 159-68. PMID 23380993 DOI: 10.3233/Jad-122026  0.414
2013 Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, et al. Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 151-9. PMID 23375564 DOI: 10.1016/J.Jalz.2012.08.008  0.351
2013 Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, ... ... Morris J, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/J.Jalz.2012.03.003  0.327
2013 Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, ... ... Morris J, et al. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 176-88. PMID 23043900 DOI: 10.1016/J.Jalz.2012.03.002  0.364
2013 Williams MM, Storandt M, Roe CM, Morris JC. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S39-44. PMID 22858530 DOI: 10.1016/J.Jalz.2012.01.005  0.427
2013 Welsh-Bohmer KA, Fillenbaum GG, Morris JC. Albert Heyman, MD (1916-2012) Neurology. 80: 1184-1185. DOI: 10.1212/Wnl.0B013E3182897160  0.363
2013 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Morris JC, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 45: 712-712. DOI: 10.1038/Ng0613-712A  0.35
2013 Ruvolo D, Chasse R, Dreyfus DM, Vernon E, Grant E, Morris J, Hassenstab J. Attenuation of practice effects on neuropsychological performance is a potential marker of preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.222  0.381
2013 Chasse R, Benzinger T, Grant E, Cairns N, Fagan A, Morris J, Hassenstab J. Alzheimer's disease biomarkers and normative cognitive data: The SuperNorms approach Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.220  0.41
2013 Wang L, Brier M, Snyder A, Thomas J, Fagan A, Xiong C, Benzinger T, Holtzman D, Morris J, Ances B. P2-159: Cerebrospinal fluid beta-amyloid 42, tau, phosphorylated tau 181, and resting state functional connectivity Alzheimer's & Dementia. 9: P405-P406. DOI: 10.1016/J.Jalz.2013.05.804  0.324
2013 Thomas J, Brier M, Bateman R, Snyder A, Benzinger T, Xiong C, Raichle M, Sperling R, Mayeux R, Ghetti B, Ringman J, Salloway S, McDade E, Rossor M, Schofield P, ... ... Morris J, et al. IC-P-184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 9: P105-P105. DOI: 10.1016/J.Jalz.2013.05.181  0.364
2013 Cruchaga C, Harari O, Kauwe J, Bales K, Pickering EH, Bertelsen S, Fagan A, Holtzman D, Morris J, Goate A. P4-002: Cerebrospinal heart fatty-acid-binding protein as a biomarker for Alzheimer's disease Alzheimer's & Dementia. 9: P705-P705. DOI: 10.1016/J.Jalz.2013.05.1390  0.342
2013 Wang L, Ercole L, Blazey T, Benzinger T, Hassenstab J, Morris J, Ances B. IC-P-114: A refined cortical signature of Alzheimer's disease Alzheimer's & Dementia. 9: P69-P69. DOI: 10.1016/J.Jalz.2013.05.111  0.37
2013 Wang L, Brier M, Snyder A, Thomas J, Fagan A, Xiong C, Benzinger T, Holtzman D, Morris J, Ances B. IC-P-113: Cerebrospinal fluid beta-amyloid 42, tau, ptau181 and resting state functional connectivity Alzheimer's & Dementia. 9: P68-P69. DOI: 10.1016/J.Jalz.2013.05.110  0.312
2013 Gordon B, Blazey T, Allison S, Morris J, Benzinger T, Head D. IC-P-104: Characterization of cortical microstructural changes in Alzheimer's disease Alzheimer's & Dementia. 9: P60-P60. DOI: 10.1016/J.Jalz.2013.05.101  0.569
2013 Blazey T, Jack C, Kantarci K, Preboske G, Ringman J, Brickman A, Raichle M, Hornbeck R, Saykin A, Salloway S, McDade E, Rossor M, Fox N, Thompson P, Correia S, ... ... Morris J, et al. Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.100  0.367
2013 Brier M, Thomas J, Fagan A, Holtzman D, Benzinger T, Morris J, Ances B. IC-P-085: Early pathological changes due to Alzheimer's disease are detected by graph theoretical measures of functional connectivity Alzheimer's & Dementia. 9: P50-P50. DOI: 10.1016/J.Jalz.2013.05.082  0.357
2013 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Ances B, Sullivan C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, ... ... Morris J, et al. IC-P-082: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN Alzheimer's & Dementia. 9: P49-P50. DOI: 10.1016/J.Jalz.2013.05.079  0.359
2013 Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Morris J, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075  0.375
2013 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Ances B, Sullivan C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, ... ... Morris J, et al. O4-03-03: Disrupted functional connectivity in autosomal dominant Alzheimer's disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 9: P684-P685. DOI: 10.1016/J.Jalz.2013.04.348  0.349
2013 Vos S, Xiong C, Grant E, Visser PJ, Cairns N, Morris J, Holtzman D, Fagan A. O4-02-03: Using cerebrospinal fluid markers to identify stages of National Institute on Aging and Alzheimer's Association proposed criteria for preclinical Alzheimer's disease and its prognosis Alzheimer's & Dementia. 9: P682-P682. DOI: 10.1016/J.Jalz.2013.04.342  0.397
2013 Benitez B, Karch C, Jin SC, Carrel D, Cooper B, Bertelsen S, Morris J, Holtzman D, Goate A, Cruchaga C. Rare variants in APP and PSEN1 genes associated with extreme levels of beta-amyloid 42 and tau protein in cerebrospinal fluid Alzheimers & Dementia. 9: 680. DOI: 10.1016/J.Jalz.2013.04.338  0.302
2013 Leung YY, Toledo J, Nefedov A, Polikar R, Raghavan N, Xie S, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Deerlin VV, Kling M, Chen-Plotkin A, Mailman M, ... ... Morris J, et al. Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.059  0.333
2013 Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Morris J, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017  0.353
2012 Li T, Wang HL, Yang YH, Galvin JE, Morris JC, Yu X. [The reliability and validity of Chinese version of AD8]. Zhonghua Nei Ke Za Zhi. 51: 777-80. PMID 23290975  0.302
2012 Huang Y, Potter R, Sigurdson W, Kasten T, Connors R, Morris JC, Benzinger T, Mintun M, Ashwood T, Ferm M, Budd SL, Bateman RJ. β-amyloid dynamics in human plasma. Archives of Neurology. 69: 1591-7. PMID 23229043 DOI: 10.1001/Archneurol.2012.18107  0.312
2012 Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93  0.437
2012 Wang L, Roe CM, Snyder AZ, Brier MR, Thomas JB, Xiong C, Benzinger TL, Morris JC, Ances BM. Alzheimer disease family history impacts resting state functional connectivity. Annals of Neurology. 72: 571-7. PMID 23109152 DOI: 10.1002/Ana.23643  0.404
2012 D'Angelo GM, Lazar NA, Zhou G, Eddy WF, Morris JC, Sheline YI. Bootstrapping GEE models for fMRI regional connectivity. Neuroimage. 63: 1890-900. PMID 22906513 DOI: 10.1016/J.Neuroimage.2012.08.036  0.302
2012 Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, ... ... Morris JC, et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 79: 897-905. PMID 22855860 DOI: 10.1212/Wnl.0B013E318266Fa70  0.452
2012 Cruchaga C, Kauwe JS, Nowotny P, Bales K, Pickering EH, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Human Molecular Genetics. 21: 4558-71. PMID 22821396 DOI: 10.1093/Hmg/Dds296  0.357
2012 Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Morris JC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753  0.431
2012 Brier MR, Thomas JB, Snyder AZ, Benzinger TL, Zhang D, Raichle ME, Holtzman DM, Morris JC, Ances BM. Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8890-9. PMID 22745490 DOI: 10.1523/Jneurosci.5698-11.2012  0.422
2012 Oneal MJ, Trujillo MA, Davydova J, McDonough S, Yamamoto M, Morris JC. Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy. Human Gene Therapy. 23: 951-9. PMID 22694073 DOI: 10.1089/Hum.2012.047  0.302
2012 Reiter K, Alpert KI, Cobia DJ, Kwasny MJ, Morris JC, Csernansky JC, Wang L. Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD. Neuroimage. 61: 525-32. PMID 22503937 DOI: 10.1016/J.Neuroimage.2012.03.083  0.42
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Morris JC, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7  0.461
2012 Tarawneh R, Lee JM, Ladenson JH, Morris JC, Holtzman DM. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology. 78: 709-19. PMID 22357717 DOI: 10.1212/Wnl.0B013E318248E568  0.439
2012 Storandt M, Head D, Fagan AM, Holtzman DM, Morris JC. Toward a multifactorial model of Alzheimer disease. Neurobiology of Aging. 33: 2262-71. PMID 22261556 DOI: 10.1016/J.Neurobiolaging.2011.11.029  0.441
2012 Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB. 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Archives of Neurology. 69: 72-7. PMID 22232345 DOI: 10.1001/Archneurol.2011.761  0.375
2012 Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, Holtzman DM, Morris JC. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Archives of Neurology. 69: 636-43. PMID 22232206 DOI: 10.1001/Archneurol.2011.845  0.374
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, ... Morris JC, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  0.391
2012 Wang L, Fagan AM, Shah AR, Beg MF, Csernansky JG, Morris JC, Holtzman DM. Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 26: 314-21. PMID 22156755 DOI: 10.1097/Wad.0B013E31823C0Cf4  0.449
2012 Vlassenko AG, Benzinger TL, Morris JC. PET amyloid-beta imaging in preclinical Alzheimer's disease. Biochimica Et Biophysica Acta. 1822: 370-9. PMID 22108203 DOI: 10.1016/J.Bbadis.2011.11.005  0.478
2012 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: S1-68. PMID 22047634 DOI: 10.1016/J.Jalz.2011.09.172  0.482
2012 Zaleta AK, Carpenter BD, Porensky EK, Xiong C, Morris JC. Agreement on diagnosis among patients, companions, and professionals after a dementia evaluation. Alzheimer Disease and Associated Disorders. 26: 232-7. PMID 22037598 DOI: 10.1097/Wad.0B013E3182351C04  0.35
2012 Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, ... ... Morris JC, et al. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 377-87. PMID 22027014 DOI: 10.3233/Jad-2011-110824  0.405
2012 Huang Y, Potter R, Sigurdson W, Santacruz A, Shih S, Ju YE, Kasten T, Morris JC, Mintun M, Duntley S, Bateman RJ. Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Archives of Neurology. 69: 51-8. PMID 21911660 DOI: 10.1001/Archneurol.2011.235  0.421
2012 Ceyhan E, Beg MF, CeritoÄŸlu C, Wang L, Morris JC, Csernansky JG, Miller MI, Ratnanather JT. Metric distances between hippocampal shapes indicate different rates of change over time in nondemented and demented subjects. Current Alzheimer Research. 9: 972-81. PMID 21875412 DOI: 10.2174/156720512803251138  0.307
2012 Galvin JE, Meuser TM, Morris JC. Improving physician awareness of Alzheimer disease and enhancing recruitment: the Clinician Partners Program. Alzheimer Disease and Associated Disorders. 26: 61-7. PMID 21399484 DOI: 10.1016/J.Jalz.2011.05.432  0.338
2012 Pizzie R, Hindman H, Roe C, Head D, Grant E, Morris J, Hassenstab J. Physical Activity and Cognitive Trajectories in Cognitively Normal Middle-Aged and Elderly Adults: Longitudinal Findings from the Adult Children Study (S24.002) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S24.002  0.32
2012 Galvin JE, Morris JC. Reply: The impact of dementia prevalence on the utility of the AD8 Brain. 135. DOI: 10.1093/Brain/Awr136  0.356
2012 Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, ... ... Morris J, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655  0.381
2012 Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, ... ... Morris J, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654  0.363
2012 Sutphen CL, Shah AR, Amos M, Vlassenko AG, Benzinger TL, Holtzman DM, Morris JC, Fagan AM. O1-01-06: Longitudinal changes in cerebrospinal fluid biomarkers of Alzheimer's disease during middle-age in cognitively normal individuals with a positive family history Alzheimer's & Dementia. 8: P86-P86. DOI: 10.1016/J.Jalz.2012.05.207  0.385
2012 Benzinger T, Blazey T, Ances B, Raichle M, Ances B, Snyder A, Su Y, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Morris J, et al. IC-P-128: Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study Alzheimer's & Dementia. 8: P68-P69. DOI: 10.1016/j.jalz.2012.05.1858  0.382
2012 Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Morris J, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172  0.353
2012 Holtzman D, Sutphen C, Tarawneh R, Ladenson J, Shah A, Morris J, Fagan A. Longitudinal CSF changes in markers of neurodegeneration and utilization of these markers in predicting conversion from normal cognition to cognitive impairment Alzheimers & Dementia. 8: 606. DOI: 10.1016/J.Jalz.2012.05.1623  0.311
2012 Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Morris J, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132  0.437
2012 Galvin J, Roe C, Morris J. The AD8 dementia screening test detects mild cognitive impairment Alzheimers & Dementia. 8: 483. DOI: 10.1016/J.Jalz.2012.05.1307  0.339
2012 Bateman R, Morris J. F3-04-02: The dominantly inherited Alzheimer's network trials: An opportunity to prevent Alzheimer's disease Alzheimer's & Dementia. 8: P426-P426. DOI: 10.1016/J.Jalz.2012.05.1135  0.38
2012 Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, ... ... Morris J, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064  0.382
2012 Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, ... ... Morris J, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052  0.335
Show low-probability matches.